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SUMMARY 
 
ENGLISH 
 
Adaptation to a world with 20% oxygen in its atmosphere is closely linked to the ability of 
organisms to couple with oxygen's harmful potential. DNA damage by reactive oxygen species 
(ROS) is a major issue, since insufficient elimination of damaged bases (lesions) from DNA is 
deleterious and leads to cancer. Repair of DNA lesions including the most mutagenic 8-oxo-guanine 
(8-oxo-G) relies on base excision repair (BER) - a complex orchestra of 30 different proteins-, 
which are required to be subtly regulated in order to keep DNA repair activate only when necessary, 
thus preventing genomic instability. In the past years mechanisms regulating BER dependent on the 
cell cycle or in response to severe DNA damage rapidly induced by oxidizing agents and irradiation 
have been uncovered. However, how BER is regulated when DNA is continuously damaged 
through extensive exposure to ROS, generated by excessive oxygen consumption (like observed 
during tissue growth and regeneration), or contrary, in deprivation of oxygen (like tumor hypoxia), 
has not been clearly defined so far. Moreover, mechanisms controlling BER in these responses and 
their role in cell physiology and/or tumorgenesis have not been elucidated.   
In this thesis work, the expression of four core BER genes – the two DNA glycosylases 
hOGG1 and MUTYH and the two DNA polymerases λ and β – was activated by hypoxia, and, in 
spite of gradual decline, was maintained, during the entire period of re-oxygenation, thus resulting 
in increased capacity of hOGG1 initiated BER, both under hypoxia and upon re-oxygenation. The 
capacity of hOGG1 mediated BER was controlled via the HIF-1α pathway, that under hypoxia 
induced both mRNA and protein levels of hOGG1 and DNA polymerase β. However, during re-
oxygenation, the activity of the hOGG1 protein was also influenced by protein kinase B (PKB, Akt) 
dependent phosphorylation. Phosphorylation of the hOGG1 on Ser51 by Akt2 increased activity of 
hOGG1 mediated BER upon re-oxygenation, due to accelerated nuclear translocation. 
Simultaneously, the capacity of MUTYH initiated BER was increased under hypoxia, as a result of 
elevated expression of DNA polymerase λ, which was caused by the mTOR kinase. Although, 
increased BER capacity of hypoxic cells was not promoting their survival or tolerance to DNA 
damage, re-oxygenated cells were extremely resistant to various types of DNA damage. This 
suggested that hypoxic preconditioning is a main way to alter BER capacity under changing oxygen 
availability and consumption. Furthermore, the expression of the four core BER genes, and BER 
function was uncoupled from the amount of ROS generated or from the content of oxidative lesions 
in DNA, either during hypoxia, re-oxygenation, or their transitions. Finally, the expression of BER 
genes and the capacity of BER were elevated in solid tumors of human and animals. Like observed 
in case of non-transformed cells, upon re-oxygenation, it allowed revived tumor cells to tolerate 
excessive DNA damage caused by multiple, also therapeutic, agents, and thus determined their ex 
vivo resistance to anti-cancer treatment. 
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 GERMAN 
 
Die Anpassung an eine Welt mit ihren 20% atmosphärischen  Sauerstoff ist eng mit der 
Fähigkeit eines Organismus verknüpft, auch mit seinem schädlichen Potential umzugehen. Die 
Reparatur der DNA Schäden, die durch sogenannte “Reactive Oxygen Species“ (ROS) entstehen, ist 
sehr wichtig, da eine ungenügende DNA Reparatur zu Krebs führen kann. Die DNA Reparatur, 
welche die sogenannten 8-oxo-guanine (8-oxo-G) entfernen kann, bezeichnet man als 
Basenexzisionsreparatur (BER). Diese umfasst 30 verschiedene Proteine, welche zu korrekten 
Reparatur, sowie zur Verhinderung der genetischen Instabilität beitragen. In den letzten Jahren 
wurden regulatorische Mechanismen entdeckt, die auf eine Abhängigkeit der BER vom Zellzyklus 
und der Checkpointkontrolle hindeuten. Hingegen ist nicht bekannt, wie die BER auf hohe Mengen 
ROS reagiert, wie sie bei erhöhtem Sauerstoffverbrauch der Zelle entstehen (z. Bsp. beim 
Gewebewachstum und bei der Geweberegeneration). In Gegensatz dazu ist ebenfalls bei der 
sogenannten Sauerstoffunterversorgung wenig bekannt (z. Bsp. Hypoxie bei Tumoren). Dabei weiß 
man vor allem noch sehr wenig über deren Regulationsmechanismen. 
In dieser Dissertationsarbeit wurden vier wichtige BER Proteine untersucht. Es handelt sich 
um die beiden DNA Glykosylasen hOGG1 und MUTYH und die beiden DNA Polymerasen λ und 
β. Sie wurden in Bezug auf Hypoxie mit anschließender Reoxygenierung getestet. Die hOGG1 
initiierte BER wurde sowohl unter Hypoxie als auch während der Reoxygenierung massiv 
stimuliert. Die Kontrolle erfolgte durch den HIF1a Regulationsweg, indem sowohl die mRNA als 
auch die Proteine Mengen von hOGG1 als auch von DNA Polymerase β induziert wurden. Im 
Weiteren wurde während der Reoxygenierung die Aktivität von hOGG1 durch Phosphorylierung 
durch die Proteinkinase B (PKB, Akt) beeinflusst. Phosphorylierung von hOOG1 am Ser51 by Akt2 
erhöhte die Aktivität von hOGG1 vermittelter BER während der Reoxygenierung, indem hOGG1 
rascher in den Zellkern transportiert wurde. Auf der anderen Site wurde die Aktivität von MUTYH 
iniziierter BER unter Hypoxie stimuliert. Dies weil die Expression von DNA Polymerase λ als 
Folge der mTOR Kinase erhöht war. Überraschenderweise waren reoxygenierte Zellen sehr 
resistent gegen DNA Schäden. Dies deutete darauf hin, dass die Zellen konditioniert sind auf 
häufigen Wechsel in ihrer Sauerstoffumgebung. Im Weiteren waren die vier erwähnten BER 
Proteine unabhängig vom der Menge produzierten ROS oder von der Menge der effektiven 
Sauerstoffschäden, die während der Hypoxie und der Reoxygenierung entstanden. Schließlich 
wurden in Tumoren von Mensch und Hund erhöhte BER Werte gefunden. Dies deutet darauf hin, 
dass Tumorzellen nach Reoxygenierung höhere DNA Schäden überleben können und somit eine 
Resistenz gegen Chemotherapeutika entwickeln können. 
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I. INTRODUCTION 
 
I.1. OXYGEN HOMEOSTASIS 
 
I.1.1. OXYGEN, HYPEROXIA AND HYPOXIA 
 
Oxygen (atomic number 8, chemical symbol O) is the most abundant chemical element in the 
biosphere, and is the third element in the universe, after hydrogen and helium. It is the most 
common element in the Earth’s crust (42.9%, by mass) and the second most common component of 
the Earth's atmosphere, constituting up 20.8% of its volume and 23.1% of its mass (some 1015 
million) (Hampel, 1968).  
Historically, aerial substance responsible for combustion was first discovered in 1772 by 
Swedish pharmacist Carl Wilhelm Scheele, and few years later it was isolated and named “oxygen”, 
by the French chemist Antoine Lavoisier (Ephraim et al., 1939). He derived this name from the 
Greek roots ξύς (oxys) ("acid", literally "sharp", referring to the sour taste of acids) and -γενής (-
genēs) ("producer", literally "begetter"), because it was mistakenly thought, at that time, that all 
acids require oxygen in their composition.  
In atmosphere over 99% of the oxygen is the isotope O16 that forms the diatomic molecule 
O2, a very pale blue odorless and tasteless gas. O2 molecule exists in two main states. At its ground 
and inactive state, it is a triplet, having two unpaired electrons occupying two degenerate molecular 
orbitals that make the double bond stable, and thus the entire molecule low reactive and 
paramagnetic. In an active high-energy state, O2 is singlet and has all the electron spins paired 
which makes singlet O2 to be highly reactive towards common organic molecules than is molecular 
oxygen per se. In nature, free oxygen, mainly in its singlet state, is commonly formed from water 
during photosynthesis, using the energy of sunlight (Krieger-Liszkay, 2005), or produced in the 
troposphere by the photolysis of ozone by light of short wavelength. In the human body free oxygen 
is also generated by the immune system as a source of active oxygen needed to eliminate invading 
microorganisms (Wentworth et al., 2002). 
Originally discovered as the “life” gas, it was only two centuries later explained how oxygen 
is involved in life supporting processes, like energy generation via oxidative phosphorylation in 
mitochondria (Mitchell and Moyle, 1967) and photosynthesis in chloroplasts (Bryant and Frigaard, 
2006), further emphasizing its importance for cell metabolism and physiology.	 Therefore, organs 
and tissues in the human body also require constant oxygen supply to maintain their function and to 
balance energy homeostasis.  
The oxygen content in the body of a living organism is usually highest in the respiratory 
system, and decreases along the arterial system, the peripheral tissues and the venous system, 
respectively. Therefore, the oxygen content is often given as the partial pressure, which is the 
pressure, which oxygen would have if it would alone occupy the entire volume (Henrickson, 2005). 
The normal O2 concentration to which cells in the human body are exposed varies from 21% in the 
upper airway to 1% at the corticomedullary junction of the kidney (Table 1) (Semenza, 2010). The 
blood is oxygenated in the lung alveoli, where the level of oxygen reaches 13–16%. As the blood is 
transported through the body, the oxygen levels decrease. Venous blood contains around 5% 
oxygen and in certain peripheral tissues, oxygen levels are probably substantially lower than that 
(Webb et al., 2009). Apart of such a broad range of oxygen exposure, the majority of human tissues 
optimally functions in O2 concentrations that do not exceed 9%, but also do not go below 2%. 
Conditions of the high ventilation (hyperoxia) or shortage of O2 supply (hypoxia) are unfavorable, 
toxic and stressful.  
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Table 1: Partial pressures of oxygen in the human body (PO2) 
 
Unit Alveolar pulmonary oxygen Arterial blood oxygen Venous blood oxygen 
 
kPa 14.2* 11-13 4.0-5.3 
 
mmHg 107 75-100 30-40 
 
 * - data from (Henrickson, 2005) 
 
Hyperoxia is defined as an excess of oxygen in the lungs or other body tissues, which can be 
caused by breathing air or oxygen at pressures greater than normal atmospheric. The latter is rare 
physiological condition and is mainly related to medical practice and toxicity in association with 
oxygen therapy or other rapid exposures to hyperbaric oxygen. 
Hyperbaric (high-pressure) therapy is used to treat diseases that impair the body's ability to 
take up and use gaseous oxygen, e.g. emphysema, pneumonia and certain heart disorders (Jorgensen 
et al., 2008). In such cases, oxygen can lead to toxicity, which usually begins to occur at partial 
pressures more than 50 kilopascals (kPa), or 2.5 times the normal sea-level O2 partial pressure of 
about 21 kPa. Convulsions and seizures are visible as toxic effects, (Fig. 1). In clinical settings, 
however, this is not a major problem except for patients that are on mechanical ventilators, since the 
gas supplied through oxygen masks in medical applications is typically composed of 30%–50% O2 
only by volume (about 30 kPa at standard pressure). Finally, stationary of premature babies in 
incubators containing O2-rich air was discontinued due to high rate of associated blindness 
(Jorgensen et al., 2008).  
 
 
 
Fig. 1: Main symptoms of oxygen toxicity (Dharmeshkumar N Patel, 2003) 
 
Hypoxia, known as oxygen starvation, in contrast to hyperoxia, is a common physiological 
and pathophysiological condition. Since it is difficult to define hypoxia with a specific oxygen 
concentration threshold value so most of current practical definitions consider, hypoxia occurs when 
oxygen delivery does not meet the demand of a certain organ, tissue or cell (Papandreou et al., 
2005). Hypoxia can appear under the following circumstances (Vaupel and Harrison, 2004): 1) the 
partial O2 pressure is low in arterial blood due to pulmonary diseases or high altitude (hypoxemic 
hypoxia); 2) the capacity of O2 in blood is reduced as a result of anemia, methemoglobin formation, 
or carbon monoxide poisoning (anemic hypoxia); 3) insufficient blood perfuse to tissues 
(circulatory or ischemic hypoxia); 4) the diffusion geometry is altered such as increased diffusion 
distances, concurrent versus countercurrent blood flow within micro vessels (diffusional hypoxia) 
and 5) intoxication causes cells to be unable to use O2 as in cyanide poisoning (histotoxic or 
cytotoxic hypoxia). 
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For experimental cell cultures, hypoxia is defined as 0.2-2.0% O2 (usually complemented 
with 5% CO2, the rest is nitrogen). At this level the toxicity and growth inhibition to cells are not 
present, and cellular responses to hypoxia can be measured (Papandreou et al., 2005). 
 
I.1.2. ADAPTION TO HYPOXIA, HIF and mTOR 
 
Once an organism or a single cell is exposed to hypoxia, it may react with switching on 
mechanisms that regulate responses to changes in oxygen tension and allow adaption to that. These 
mechanisms are multiple and act dependently on the level of exposure. In response to global 
hypoxia, such as what occurs at high altitude, the physiology of the entire organism is modified by 
e.g. increasing the respiration rate, whereas, localized hypoxia, such as at the site of an injury, 
modifies local cell signaling with confined effects on blood vessel recruitment. 
In the mammalian organism specialized chemoreceptor cells, in the carotid and 
neuroepithelial bodies, sense oxygen. Contributions from mitochondrial production of H+ and direct 
membrane effects lead to a reduction in outward potassium current in these cells during hypoxia. 
The resulting membrane depolarization, the calcium entry and the neurotransmitter release, 
immediately alter the physiology of the organism by stimulating an increase in respiratory and heart 
rates (Lahiri et al., 2006).  
On the other hand, responses to chronic hypoxia, may take several hours to develop and 
generally result in widespread changes in gene expression. In general, there are two adaptation 
choices in chronic hypoxia: reduction of oxygen consumption by switching to an anaerobic 
metabolism and by decreasing energy usage (i.e., reduced proliferation) or, alternatively, increasing 
oxygen delivery to cells via increased erythropoiesis and blood vessel formation (Mole and 
Ratcliffe, 2008). 
No matter which mechanisms are involved and how their regulation differs among various 
organisms or cells, they all work through hypoxia-induced molecules. The hypoxia-dependent 
generation and regulation of these molecules, to a large extent, are managed at the transcriptional 
level by hypoxia-inducible factors. 
Hypoxia inducible factor (HIF) HIF-1 was originally discovered as a transcription factor 
inducing EPO transcription in response to hypoxia (Semenza and Wang, 1992). Five years later 
HIF-2 (also named EPAS-1 or HLF-1) was discovered and showed a close sequence similarity to 
HIF-1 (Ema et al., 1997) and eventually HIF-3 was reported as a negative regulator of HIF induced 
transcription (Makino et al., 2001). HIF-1 is still the most studied HIF and increasing research is 
focusing on HIF-2. Little, however, is still known about HIF-3 (Fig. 2). 
 
 
 
Fig. 2: Domain structure of HIF subunits. Basic structure of the mammalian HIF-1α, HIF-2α, and HIF-1β proteins, 
showing conserved functional domains including basic helix-loop-helix (bHLH), Per-Arnt-Sim homology (PAS), oxygen-
dependent degradation (ODD), and N-terminal transactivation (NAD) and C-terminal transactivation (CAD) domains (Bracken et 
al., 2003). 
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The HIFs belong to the basic helix-loop-helix PAS (bHLH-PAS) domain family of 
transcription factors and are active as heterodimers consisting of one HIF-α subunit and one HIF-β 
subunit. Under hypoxic conditions HIF-lα and HIF-2α rapidly accumulate and bind HIF-1β (also 
called ARNT), recruit the transcriptional co-activators p300 and CREB-binding protein (CBP) and 
binds to hypoxia-response elements (HREs), thus activating the transcription of several hundred of 
different hypoxia-responsive genes (Fig. 3). HIF-1 binding is only detected at genes with increased 
expression but it can also regulate transcription of many genes in a negative way indirectly by 
regulating transcriptional repressors and microRNAs (Mole et al., 2009). 
 
 
 
Fig. 3: Oxygen-dependent regulation of HIF-α. Prolyl and asparaginyl hydroxylation of HIF-α modulate the stability and 
transcriptional activity of HIF-α in an oxygen-dependent manner, and therefore the overall activity of HIF target genes. For details 
see text and (Bardos and Ashcroft, 2005). 
 
HIF-α subunits are continuously transcribed and translated and its regulation is primarily 
post-translational (Gordan and Simon, 2007). The expression of HIF-α protein is tightly regulated in 
an oxygen dependent way (Fig. 3). In the presence of oxygen, prolyl hydroxylase domain proteins 
(PHDs) hydroxylate HIF-α, generating a binding site for the von Hippel-Lindau (VHL) protein, 
which is a component of an ubiquitin ligase complex. HIF-α is then polyubiquitinylated and thus a 
target to proteasomal degradation. Another way in which oxygen regulates HIF-α is via the factor 
inhibiting HIF-1 (FIH-1) protein that can hydroxylate HIF-α, thereby preventing binding of the co-
activators p300 and CBP. This results in an inhibition of transcription activation (Kaelin and 
Ratcliffe, 2008). HIF-α can also be regulated in oxygen-independent ways, e.g. by mutations in the 
regulating proteins. The most obvious example is mutations in VHL that impair the ability of pVHL 
to ubiquitinate HIF-α leading to HIF-α accumulation in non-hypoxic cells. These mutations are 
most common in renal cell cancer and hemangioblastoma (Kaelin and Ratcliffe, 2008). 
HIF-α can also be accumulated due to increased transcription and translation. Several 
different important signaling pathways in tumor cells have been associated with increased HIF-α 
expression. Different growth factor signaling systems that have been reported to increase HIF-α 
protein levels include EGFR in prostate cancer (Zhong et al., 2001), HER2 (Laughner et al., 2001) 
and RAS in breast cancer (Blancher et al., 2001), and VEGF in colon cancer (Calvani et al., 2008). 
There were several different growth factors reported to up-regulate or stabilize HIF-lα expression 
(Bardos and Ashcroft, 2004). The effects on HIF-α expression modulated by these different growth 
factors seem to be dependent on signaling pathways central to the tumor cells, i.e. the PI3K/AKT, 
the mTOR and the RAS/MAPK pathways (Bardos and Ashcroft, 2004). Differences in HIF-1 and 
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HIF-2 function are well studied in the context of embryonic development. H1F-1α-/- mouse embryos 
die in mid gestation due to decreased erythropoiesis and cardiovascular malformations and neural 
tube defects, indicating that HIF-1 is needed for normal development (Yoon et al., 2006). At the 
same time, H1F-2α knockout mice models have generated differing phenotypes. Most H1F-2α-/- 
mice die in utero (Compernolle et al., 2002) and the few mouse strains that survived showed 
multiple organs pathology (Scortegagna et al., 2003) or died during neonatal period due to a severe 
respiratory distress syndrome (Compernolle et al., 2002). Generalizing these results it seems that 
most of the H1F-2α knockout mice experienced defects in vascular development of different organs 
and the different phenotypes may be due to different genetic backgrounds. The discrepancies of 
HIF-1 and HIF-2 involvement in mouse embryo development can also be explained by the 
difference in their expression. HIF-lα mRNA was more abundantly expressed and especially high in 
the myocardium, primitive gut and neuroepithelium in mouse embryonic development whereas 
HIF-2α mRNA was mostly expressed in the developing vasculature, but also found in lung, kidney, 
olfactory epithelium and adrenal gland (Carmeliet et al., 1998). In human tissues HIF-lα is 
expressed ubiquitously, whereas HIF-2α expression has been found to be restricted to endothelium, 
kidney, heart, lung, liver, pancreas, intestine and brain (Wiesener et al., 2003). 
The differences in gene regulation by HIF-1 and HIF-2, respectively, have been investigated 
in different studies using gene expression microarrays and chromatin immunoprecipitation (ChIP). 
HIF-1 seems to be the most dominant of the two in most tissues but the regulation is tissue and cell 
type specific (Lofstedt et al., 2007). Erythropoiesis, angiogenesis and glycolytic metabolism is 
regulated by several genes and is differently regulated by HIF-α subtype in different cell types 
(Gordan and Simon, 2007). It seems that HIF-lα is needed for inducing glycolytic enzymes in 
response to hypoxia whereas HIF-2α can mediate many other hypoxia-responses in angiogenesis, 
growth and metastasis. Previous studies have not found selective binding of HIF-lα or HIF-2α to 
specific loci but rather the binding to different loci seemed to be cell type specific. Recently, 
differences in HIF-lα and HIF-2α regulated gene transcription in the breast cancer cell line MCF-7 
was reported, stating that despite a large overlap in HIF-α isoform binding there were substantial 
differences in gene regulation with HIF-2α contributing very little to the overall HIF response 
(Mole et al., 2009). It seemed that HIF-lα was the most important regulator for adaptation to acute 
hypoxia. Differences in HIF-α subunit regulation by time and oxygen levels in neuroblastoma has 
been reported (Holmquist-Mengelbier et al., 2006), suggesting that HIF-lα is more important in 
acute hypoxia whereas HIF-2α is more important in response to chronic hypoxia and that HIF-2α is 
also stabilized at "normal" end-capillary O2 levels of 5%. On the other hand, HIF-lα and HIF-2α 
expression patterns differ in tumors. HIF-lα is most often found in perinecrotic zones, representing 
areas of hypoxia (Helczynska et al., 2003) whereas HIF-2α is also found in perivascular areas that 
are non-hypoxic (Holmquist-Mengelbier et al., 2006). These findings also imply different roles of 
HIF-lα and HIF-2α in tumor progression.  
At the translational level cells respond to hypoxia, involving mainly, another major regulator 
– the mammalian target of rapamycin (mTOR). It was discovered as the target for its specific 
inhibitor, rapamycin, an immunosuppressant and antibiotic, which was isolated from the bacteria 
Streptomyces hygroscopicus (Sehgal, 2003). Using RNA silencing technique it was found that 
rapamycin does not affect all mTOR functions; suggesting mTOR may be present in different 
isoforms or complexes. Indeed, two TOR complexes, mTORC1 and mTORC2 have been identified 
in yeast and later in a variety of eukaryotes (Loewith et al., 2002).  mTORC1 is rapidly and 
specifically inhibited by FKBP12-bound rapamycin but mTORC2 is not acutely rapamycin-
sensitive. However, long-term treatment with rapamycin can avoid the formation of complex 2 in 
some cell types, e.g., in endothelial cells (Sarbassov et al., 2006). The newly synthesized mTOR-
protein immediately forms a complex with FKBP12-rapamycin, which prevents association with 
rictor (Sarbassov et al., 2006). Composition of mTOR complexes defines their function and identity.  
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Regulatory associated protein of mTOR (Raptor, 150 kDa) and PRAS40 are functional parts 
of TORC1. MLST8 is also present in mTORC1, but is probably not required for all of mTORC1’s 
functions (Loewith et al., 2002). Formation of mTORC2 requires mTOR to assemble the 
rapamycin-insensitive companion of mTOR (Rictor) and mSIN1 (mammalian stress activated 
protein kinase [SAPK]-interacting protein). In mTORC2, mLST8 is a functionally and structurally 
required component. The mTOR regulatory protein rictor (also known as mAVO3) is a large protein 
(200 kDa) and contains no obvious catalytic motifs, but repetitive domains, similar to mSIN1 
(Loewith et al., 2002) (Fig. 4).  
mTOR integrates various signals to regulate cell growth. Four major inputs have been 
implicated in TOR signaling: growth factors, nutrients, energy, and stress (Wullschleger et al., 
2006) (Fig. 5). 
 
 
 
Fig. 4: Schematic presentation of (a) mTOR structure and (b) the mTOR complexes. For details see text (Wullschleger et 
al., 2006). 
 
In response to environmental stress, such as hypoxia or low energy, cells down regulate 
energy-demanding processes and arrest growth.  
 
 
 
Fig. 5:  The mTOR-signaling network. Activation processes are marked by arrows and inhibition by T-bars. For details 
see text and (Wullschleger et al., 2006). 
 
Upon hypoxia, TOR signaling is inhibited and protein synthesis is thereby down regulated. 
Hypoxia is transduced to mTORC1 via the two homologous proteins REDD1 and REDD2. The 
expression of REDD is up-regulated upon hypoxia by HIF-1 (Brugarolas et al., 2004). However, 
stabilization of HIF-1α under hypoxia has been shown to depend on active mTOR-signaling 
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suggesting that hypoxia activates mTOR signaling (Hudson et al., 2002). Furthermore, hypoxia has 
been shown to increase proliferation of lung adventitial fibroblasts, endothelial cells and of 
angiogenesis in vitro in mTOR dependent way (Humar et al., 2002). Therefore hypoxia can inhibit 
mTOR signaling in some processes and activate it in others. 
 
I.1.3. TUMOR HYPOXIA AND THERAPY RESISTANCE 
 
Balanced oxygen homeostasis is the basis for normal function of a human body as well as 
their individual cells. Subtle regulation of hypoxic responses helps to adapt to the changes in 
oxygen availability. Incorrect hypoxic adaptation has been associated with several human diseases, 
such as congenital polycythemia, vascular ischemic disease and pulmonary hypertension (Semenza, 
2011). Among multiple clinical manifestations of disordered oxygen homeostasis, the most notable 
is coordinated adaptation to hypoxia in cancer, known as tumor hypoxia. 
Early reports demonstrated that tumors grow in close proximity to blood vessels, and that 
tumor cells located more than 180 µm away from blood vessels exhibit considerable degree of 
necrosis (Thomlinson and Gray, 1955). This distance correlates with the diffusion limit of oxygen 
(100-150 µm), when it passes from the capillary network and is metabolized within tissues. Similar 
to normal cells and tissues, cancer cells require supply of oxygen and nutrients to maintain 
membrane transport, chemical synthesis, growth and overall homeostasis. In addition elimination of 
waste products by the blood circulation is very important. When solid tumors expand in size, their 
needs for oxygen are also increased. However, the delivery of O2 to malignant and stromal cells is 
frequently reduced or even abolished due to insufficient and abnormal angiogenesis (Carmeliet and 
Jain, 2000), which in addition to anemia that can reduce the capacity of oxygen transport, thus 
ultimately leading to tumor hypoxia. These processes generate micro regions with very low or even 
zero (anoxic) oxygen partial pressures, distributed heterogeneously within most solid tumors. 
Tumor hypoxia is present when oxygen levels fall below a critical value, leading to a 
progressive decrease in ATP production.  On the other hand, critical oxygen level leading to 
hypoxia can vary widely among malignant tumors. Assessments of the tumor oxygenation status by 
both invasive and non-invasive methods indicate that oxygen PO2 of 10 mmHg (corresponding to 
1.3% O2) can be considered hypoxic (Hockel et al., 1996). This cut-off level was found to 
distinguish hypoxic cervical cancers with poor prognosis, from less-hypoxic corresponding tumors 
with significantly better survival. Tumors with a PO2 < 10 mmHg also exhibit a substantially 
increased probability of invasion and metastasis (Brizel et al., 1996). Clinical studies reveal that 
tumor hypoxia is a predictive factor for poor outcome, independent of tumor characteristics such as 
patient age, tumor size and grade, and the extent of necrosis (Hockel and Vaupel, 2001).  
Furthermore, tumor hypoxia is highly associated with increased resistance to anti-cancer 
therapy. Due to the decreased levels of available oxygen, which is the substrate for the formation of 
reactive oxygen species (ROS), causing DNA damage by photon therapy, hypoxia impedes 
radiation treatment (Gray et al., 1953). In addition, hypoxia can confer radiation resistance by 
increasing the expression of heat-shock proteins, inducing cell growth, or by inhibiting the apoptotic 
pathway (Graeber et al., 1996). Furthermore, treatment of cancer patients with chemotherapeutic 
drugs is also hampered by tumor hypoxia, due to several different mechanisms (Brown and Wilson, 
2004). The distance of hypoxic cancer cells from blood vessels causes physical inaccessibility of 
therapeutic agents. Abnormal architecture and insufficient circulation in tumor blood vessels cause 
higher interstitial pressure, which can be associated with low penetration of drugs. Furthermore, the 
therapeutic effect of several substances can be dependent on presence of oxygen. Many drugs are 
also dependent on a high range of proliferating tumor cells for proper function, and since hypoxia is 
known to be involved in decreasing proliferation, a diminished effect of the drugs might be at hand. 
In addition, hypoxia mediates an in tumor selection for cells resistant to p53-mediated apoptosis, 
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thereby desensitizing cancer cells for apoptosis-inducing agents (Graeber et al., 1996). Finally, 
hypoxia can induce expression of genes providing drug resistance, as exemplified by the mdr1 gene 
(Comerford et al., 2002). 
 
I.2. REACTIVE OXYGEN SPECIES AND DNA DAMAGE 
 
I.2.1. ROS AND OXIDATIVE STRESS 
 
Reactive oxygen species (ROS) defines a collective term that can refer to free radical 
oxygen species that have an unpaired electron in its valence shell. It also refers to certain non-
radicals that are either strong oxidizing reagents or easily converted to free radicals (Wiseman and 
Halliwell, 1996) (Fig. 6). The major ROS generated in biological systems include superoxide 
radical anions (O2●-), hydroxyl radicals (HO●), peroxyl radicals (RO2●), alkoxyl radicals (RO●), 
hydrogen peroxide (H2O2) and singlet oxygen (1O2) (Wiseman and Halliwell, 1996). Production of 
ROS can arise from both endogenous and exogenous sources. Different environmental agents 
including tobacco smoke and air pollutants contain ROS or can generate ROS. Chemical 
carcinogens (such as benzopyrene, aflatoxin and benzene), ionizing radiation and UV light (UVR-A 
and UVR-B) can also induce ROS (Loft and Poulsen, 1996). 
 
 
Fig. 6: Different types of ROS (Wiseman and Halliwell, 1996). Unpaired electrons marked as red dots. 
 
In biological systems, a major source of endogenous ROS is the complete reduction of 
oxygen, via the electron transport chain in mitochondria during cellular respiration and ATP 
production. A mammalian body produces approximately half of its body weight ATP, mostly 
through oxidative phosphorylation. Up to 5% of oxygen molecules undergoes one-electron 
reduction and are converted to superoxide radical anions (Klaunig and Kamendulis, 2004). 
Mitochondrial superoxide dismutase, an antioxidant enzyme, can catalyze the conversion of excess 
superoxide radical anions to hydrogen peroxide while catalase and glutathione peroxidase convert 
hydrogen peroxide to water (Klaunig and Kamendulis, 2004) (Fig. 7). Excess hydrogen peroxide 
can leak from the mitochondria and into the cytosol (Yu, 1994). In the presence of ferrous iron, 
hydrogen peroxide can decompose to hydroxyl radicals via the Fenton reaction: 
 
The Fenton reaction: Fe2+ + H2O2 = Fe3+ + ●OH + OH-  
 
Hydroxyl radicals are also formed in a similar manner when reduced forms of other 
transition metals such as copper come into contact with hydrogen peroxide. Iron and copper are 
sequestered in proteins including ferritin, transferrin, caeruloplasmin and metallothionein. Oxidative 
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stress has been shown to release transition metals from proteins and the released metals can then 
participate in Fenton reactions to produce hydroxyl radicals (Halliwell and Aruoma, 1991). 
 
 
 
Fig. 7: Generation and detoxification of ROS (Klaunig and Kamendulis, 2004).  
 
Various enzymes that catalyze redox reactions can also contribute to the generation of ROS. 
During CYP (define abbreviation) catalyzed metabolism, the generation of ROS can arise via 
different processes. Redox cycling in the presence of molecular oxygen and uncoupling can result in 
the generation of superoxide anion radical and hydrogen peroxide (Klaunig and Kamendulis, 2004). 
Several CYPs have the ability to generate ROS during metabolism. CYP2E1 produces a prolonged 
burst of ROS near the site of substrate oxidation during ethanol metabolism (Ekstrom and 
Ingelman-Sundberg, 1989). Other enzymes can also produce ROS when catalyzing reactions. 
Organelles derived from endoplasmic reticulum called peroxisomes are responsible for breaking 
down fatty acid chains and contain high levels of oxidase enzymes that generate hydrogen peroxide 
(Yu, 1994). The immune response can generate excess ROS in a process called the respiratory burst. 
Activated macrophages and hepatic Kupffer cells elicit rapid and transient increase in oxygen 
uptake to generate superoxide anion radicals and hydrogen peroxide (Klaunig and Kamendulis, 
2004). Release of ROS is important for a host’s defense and results in localized tissue inflammation 
and induction of genotoxicity and cytotoxicity in foreign microbes (Yu, 1994). 
Oxidative stress is an imbalance between the production of reactive oxygen species and a 
cell's ability to readily detoxify the reactive intermediates from macromolecules (proteins and fatty 
acids), or to repair the resulting damage (DNA, RNA). Disturbances in the normal cellular redox 
state can cause toxic effects through the production of ROS that damage all components of the cell, 
including proteins, lipids, and, most importantly DNA. This can lead to multiple pathologies, like 
atherosclerosis, Alzheimer's disease, premature aging and cancer (Valko et al., 2007) (Fig. 8).  
 
 
 
Fig. 8: Schematic representation of oxidative stress and its consequences (Valko et al., 2007). 
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I.2.2. BASE DAMAGES AND THEIR CONSEQUENCES 
 
Bases in DNA as well as the sugar and the phosphate backbone are constantly damaged. 
Three of the four bases normally present in DNA (cytosine, adenine, guanine), as well as 5-
methylcytosine contain exocyclic amino groups. Spontaneous hydrolytic deamination converts these 
bases to uracil, hypoxanthine, xanthine, and thymine, respectively (Fig. 9), some of which can give 
rise to mutations during replication and even repair. 
 
 
 
Fig. 9: Products formed from the deamination of bases in DNA (Friedberg and Friedberg, 2006) 
 
Spontaneous loss of bases, mostly purines, occurs at considerable rates that generate the 
cytotoxic and mutagenic apurinic/apyrimidinic (AP) sites (Nakamura et al., 1998). However, a 
major source of DNA damage is the attack by reactive oxygen species. ROS can generate mutagenic 
oxidative base lesions (e.g. 8-oxo-G) and modified bases that can block replication (e.g. thymine 
glycol) (Fig. 10) and strand breaks (Bjelland and Seeberg, 2003).  
 
 
 
Fig. 10: Common oxidative base damage in DNA (Friedberg and Friedberg, 2006) 
 
Alkylation lesions in DNA result from endogenous compounds, environmental agents and 
alkylating drugs. Alkylating agents are electrophilic compounds with affinity for nucleophilic 
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centers in DNA (Fig. 11). In general, the ring nitrogen of the bases are nucleophilic, with the N7 
position of guanine and the N3 position of adenine the most reactive, followed by O6 in guanine 
(Friedberg and Friedberg, 2006). Alkylated bases can be mutagenic (O6-mG) or can block 
replication (3-meA). Alkylation of oxygen in the phosphodiester linkage results in the formation of 
phosphotriesters, which apparently are not repaired and are assumed to be relatively harmless 
(Friedberg and Friedberg, 2006). 
The types of DNA damage (base damage or strand break), the location of the lesions in the 
genome (a promoter region, introns or exons, and actively transcribed regions or transcriptionally 
silent regions), as well as the cell cycle, and the type of the cells affect the level of mutagenicity or 
cytotoxicity of DNA lesions. 
 
 
 
Fig. 11: Products of alkylation damage of bases in DNA (Friedberg and Friedberg, 2006) 
 
Damaged bases are the most frequent form of DNA lesions (Holmquist, 1998), thus, the 
major consequence of DNA base lesions is the introduction of mutations that could result in the 
alteration of the genetic information. In this respect, a significant group of DNA base lesions are 
relatively harmless until they are “fixed” as mutations during replication. Hence, DNA repair is 
particularly important in actively replicating cells (van Loon and Hubscher, 2009). Accordingly, 
non-dividing human cells are also known to accumulate base damage in their genome (Nouspikel 
and Hanawalt, 2002).  
The oxidative base damage 8-oxo-guanine (8-oxo-G) is one of the most prevalent lesion in 
the human DNA with an estimated steady state level of 103 lesions per cell in normal tissues, and up 
to 105 lesions per cell in cancer tissues (Neeley and Essigmann, 2006). The presence of 8-oxo-G is 
often used as a biomarker to indicate the extent of oxidative stress (Klaunig and Kamendulis, 2004). 
The importance of 8-oxo-G results from its high mutagenic potential explained by its strong ability 
to functionally mimic T, thus, leading to the incorrect bypass of lesion by replicative DNA 
polymerases (Pols) α, δ, and ε (Fig. 12). The incorporation of adenine (A) instead of cytosine (C) 
opposite the lesion is 10 times more frequently performed by replicative Pols, which consequently 
might give rise to the CG->AT transversion mutations if A:8-oxo-G mismatches are left unrepaired. 
A high rate of GC-> TA transversion mutation has been found to be associated and, furthermore, 
can lead to various cancers (Pleasance et al., 2010).  
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Fig. 12: Structure of 8-oxo-G containing base pairs. The structures of the C:G and A:T base pairs (top) are compared 
with those of C:8-oxo-G and A:8-oxo-G. 8-oxo-G (bottom) differs from G by an oxo group at C8 and an NH at N7. This subtle 
change allows 8-oxo-G to base pair easily with either A or C (David et al., 2007). 
 
 
 
I.3. BASE EXCISION REPAIR 
 
I.3.1. CORE BER PROTEINS AND THEIR FUNCTIONS  
 
Base excision repair (BER) is the predominant DNA damage repair mechanism for the 
repair of the many base lesions (Fig. 13).  
 
 
 
Fig. 13: Simplified schematic representation of the long-patch and short-patch BER pathways (Christmann et al., 2003). 
 
The repair process is initiated with removal of damaged bases by the 11 known lesion-
specific DNA glycosylases and completed by either a short-patch or long-patch BER mechanism. 
Following cleavage of the phosphodiester backbone immediately 5’ to the abasic site (AP site) by 
apurinic/apyrimidinic endonuclease 1 (APE1), via the so-called short-patch BER pathway, Pol β 
hydrolyzes the resulting 5’deoxyribose phosphate (5’dRP) moiety and inserts a single nucleotide. 
Alternatively, in the long-patch repair pathway, an overhang of 2 to 12 bases is produced by Pols δ, 
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ε, or ß as a result of repair synthesis and strand displacement. The DNA overhang is excised by the 
flap endonuclease 1 (Fen1). Following DNA strand incision, repair synthesis, and end tailoring if 
necessary, a complex of DNA ligase IIIα (Lig IIIα) and X-ray repair cross-complementing protein 1 
(XRCC1) (for short-patch BER) or DNA ligase I (Lig I) (for long-patch BER) complete the repair 
by sealing the nick in DNA (Almeida and Sobol, 2007). It is currently thought that the majority of 
BER is carried out via the short-patch pathway (Hou et al., 2007). 
DNA glycosylases recognize and remove damaged or incorrect bases by hydrolyzing the N-
glycosidic bond between base and deoxyribose sugar. In human cells, 11 different glycosylases 
have been identified and characterized based on the types of modified bases removed (Jacobs and 
Schar, 2012). 8-oxo-guanine glycosylase 1 (OGG1) recognizes and releases 8-oxo-G paired with 
cytosine. Adenine-DNA glycosylase (MUTYH) identifies and removes 8-oxo-G lesions that have 
incorrectly paired with adenine during DNA replication (Cooke et al., 2003). Glycosylases have 
been further divided into 2 major subtypes, type I and type II. Type I glycosylases identify and 
remove modified bases leaving an apurinic or apyrimidinic site (AP) in DNA (Jacobs and Schar, 
2012). Type II glycosylases recognize and remove damaged bases, but can also cleave the DNA 
phosphodiester backbone by endogenous 3’-endonuclease activity, giving rise to a single strand 
break (Jacobs and Schar, 2012). In case of type I glycosylases, the phosphodiester backbone of 
DNA is cleaved by a separate AP endonuclease that can result in 5’-deoxyribose-5-phosphate 
(5’dRP) and 3’-hydroxyl DNA termini (Fortini and Dogliotti, 2007). After removal of the damaged 
base, depending on the type of BER, a single nucleotide or series of nucleotides will be inserted, are 
inserted by Pols. 
In short-patch BER, Pol β exerts lyase activity and catalyzes the release of the hemiacetal 
form of 5’dRP formed at the DNA terminus of the AP site (Christmann et al., 2003). The resulting 
gap is filled by a single nucleotide by Pol β. Lig III participates in short patch repair and seals the 
DNA backbone (Christmann et al., 2003). Both Lig III and Pol β have been shown to bind with the 
scaffolding protein X-ray repair cross-complementing protein 1 (XRCC1) for added stability and 
function (Caldecott et al., 1994) (Robertson et al., 2009). The net result of short patch repair is 
replacement of the damaged base by a single nucleotide. 
In long-patch BER, Pol β first inserts a single nucleotide at the AP site (Fortini and Dogliotti, 
2007). After Pol β dissociation, further DNA synthesis is done by Pols δ and ε, resulting in a longer 
repair patch (Christmann et al., 2003). Proliferating cell nuclear antigen (PCNA) and replication 
factor C (RF-C) are recruited to stabilize Pols δ and ε during nucleotide insertion (Stucki et al., 
1998). Fen1 cleaves the original 5’dRP flap structure (Klungland and Lindahl, 1997). PCNA forms 
a complex with Fen1 to stimulate its endonuclease activity. Finally, Lig I interacts with PCNA to 
seal the DNA backbone (Srivastava et al., 1998). The net result of long-patch BER is replacement 
of the damaged base by a series of nucleotides, 2 to 12 nucleotides in length.  
Other accessory proteins may have a role during BER. The addition of purified p53 protein 
to cell free extracts or reconstituted BER pathway stimulates BER in vitro. Conversely, 
immunodepletion of p53 from cell extracts and deficient p53 cell lines have decreased BER activity 
(Achanta and Huang, 2004). The p53 protein has been shown to directly bind and stabilize AP 
endonuclease and OGG1 glycosylase to enhance BER activity (Achanta and Huang, 2004). 
Furthermore, p53 has been shown to stabilize the interaction between Pol β and DNA termini at AP 
sites (Zhou et al., 2001). 
 
I.3.2. REGULATION OF BER AND INVOLVMENT OF O2 
 
The BER pathway is composed of over 30 different proteins, and thus, is required to be 
subtly regulated in order to maintain its function, since even mere deregulation of some of the 
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components may lead to defects in DNA repair and contribute to the development of human 
diseases (Valko et al., 2007).  
Posttranslational modifications (PTM) (Fig. 14) of BER proteins have been thoroughly 
investigated during the last few years and multiple published reports suggest that PTMs are the most 
rapid and reliable way to alter stability and enzymatic activities of core proteins in the pathway 
(Dianov et al., 2011).  
 
  
 
 
Fig. 14: Posttranslational modifications (PMTs) of proteins (left) and their chemical nature (right). For details see text 
and (Jensen, 2006). 
 
All core BER proteins studied in this thesis – hOGG1 (Dantzer et al., 2002), MUTYH 
(Parker et al., 2003), Ape-1 (Yacoub et al., 1997), DNA pol λ (Frouin et al., 2005), Pol β (Luo et al., 
2007) -, have been reported to be phosphorylated in response to different stimuli, including 
oxidizing agents and tobacco smoke (Deslee et al., 2010). Moreover, in case of hOGG1, e.g., 
phosphorylation affected its cellular localization and enzymatic activity (Dantzer et al., 2002). 
Alternatively, ubiqutination, has been reported to affect stability of Pol β (Parsons et al., 2008), Pol 
λ (Wimmer et al., 2008) and MUTYH (Markkanen et al., 2012), thus allowing for rapid 
accumulation and recruitment of the enzymes to chromatin, in case of DNA damage. In addition, 
multiple BER genes have been detected to carry in their promoter sequences, recognition sites for 
different transcription factors (Dhenaut et al., 2000), allowing additional degree of flexible 
regulation.  
Even though many data were generated in the past decade, the detailed mechanisms of BER 
regulation are still unclear. This mainly concerns the role of O2 in regulation of BER genes, where 
the current knowledge is still limited to occasional findings that might suggest a link between BER 
genes and O2. The activity of Pol ζ has been reported to be important for cultured mouse fibroblasts 
at a reduced oxygen concentration (2%), which is believed to partially mimic conditions of 
embryonic development (Lange et al., 2012). At the same time, exposure of spheroid culture of 
human skin fibroblasts at different O2 concentrations, to a low dose of ionizing radiation (IR) 
identified BER genes among induced targets (von Neubeck et al., 2012). Earlier reports trying to 
elucidate cellular functions of Pol ι revealed its dependence on HIF-1α activity (Ito et al., 2006). In 
addition, overexpression of several BER genes has been detected in 30% of 70 cases representing 
15 major human cancers (Albertella et al., 2005), including metastatic melanoma cells (Sarasin and 
Kauffmann, 2008). This tumor has been well known for its hypoxic microenvironment (Pouyssegur 
et al., 2006), which is also reported to correlate with its treatment resistance (Wirthner et al., 2008). 
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II. THESIS AIMS 
 
Although, it has been reported that BER enzymes are overexpressed in several tumors, 
neither their expression nor their role in tumorgenesis has been thoroughly studied. Moreover, how 
extensive DNA damage through continuous exposure to reactive oxygen species (ROS), generated 
in excessive oxygen consumption of, or contrary, deprivation of oxygen (like tumor hypoxia), 
affects the expression of BER proteins and which mechanisms regulate that, has not been clearly 
defined.  
The specific aims of this thesis were: 
II.1. To obtain information about the expression of BER genes, in particular the two BER 
Pols β and , the two DNA glycosylases OGG1 and MUTYH and the endonuclease APE-1, in 
dependence of O2 availability (normoxia, hypoxia, and hyperoxia); 
II.2. To identify pathways, and key factors, regulating expression of BER genes in 
dependence of O2 availability; 
II.3. To investigate the biological role of O2 regulated expression of BER proteins; 
II.4. To investigate the biological role and impact of O2 regulated expression of BER 
proteins on tumor genesis and therapy  
II.5. To analyze the expression of BER genes in human and animal tumors according to their 
grades and oxygenation status. 
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This manuscript describes how differential oxygenation affects expression of BER genes, 
including the mechanisms required that control it. Furthermore their possible biological implications 
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Summary 
 
 Base excision repair (BER) is an essential pathway required to correct oxidative DNA 
damage induced by reactive oxygen species (ROS). Subtle regulation of the pathway is 
critical to effectively combat mutagenesis and cancer. However, details of this process and 
its role in tumor genesis remain unclear. Here we demonstrate that hypoxia activates 
expression of core BER genes leading to an elevated BER functionality, which is dependent 
on signaling through hypoxia inducible factor (HIF), but not on the content of oxidative 
DNA lesions and/or production of ROS. Increased BER capacity permits excessive stress 
tolerance by healthy and neoplastic cells, thus promoting their survival. Finally, activation of 
BER in solid tumors determines their resistance to anti-cancer therapies.  
 
Significance  
 
Adaptation to a world with 20% O2 in its atmosphere is closely linked to the ability of 
cells to couple with oxygen's harmful potential. DNA damage by reactive O2 derivatives is a 
major issue, since the insufficient elimination of oxidative lesions from DNA is deleterious 
and leads to cancer. The mechanism of BER activation described here, explains how repair 
of oxidized DNA is adjusted to demands and availability of O2, especially if its concentration 
and use are rapidly changed, thus resulting in oxidative stress. Increased DNA repair 
capacity promotes the survival of cells and allows excessive stress tolerance, but, 
unfortunately, tumors can also exploit this mechanism, thereby developing treatment 
resistance. Thus, this new aspect of O2 physiology not only extends our knowledge but can 
also be the basis for better cancer treatments.  
 
Graphical Abstract 
 
 
 
Highlights  
 
- Hypoxia up-regulates BER genes increasing the DNA repair capacity of a cell 
- The HIF pathway, but not the amount of ROS or base damages, regulates core BER genes 
- Elevated BER functionality increases the cell survival due to genotoxic stress tolerance  
- Activation of BER in tumors contributes to their therapeutic resistance 
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Introduction  
 
Oxygen, which constitutes 20% of the earth’s atmosphere, is the most abundant 
element in the human body (65%) (Maltepe and Saugstad, 2009). Molecular oxygen (O2) is 
indispensable for aerobic organism to produce energy by oxidative phosphorylation in the 
mitochondria. In this process the reduction of O2 to water by the mitochondrial electron 
transport chain enables the conversion of adenosine diphosphate (ADP) into adenosine 
triphosphate (ATP), a universal form of intracellular energy source. The consequence of this 
reaction, is the formation of reactive oxygen species (ROS) which in spite of their 
physiological value can also lead to toxic effects, upon accumulation (Bertram and Hass, 
2008). Consequences of these accumulations are diseases such as cancer and 
neurodegeneration as well as premature aging. 
ROS are constantly produced in the cellular metabolism and account for up to 95% of 
all radicals affecting eukaryotic cells through their life cycle. Additional 5% are encountered 
from exogenous sources, like UV irradiation and environmental pollution (Castro and 
Freeman, 2001). The majority of ROS molecules are detoxified via cellular antioxidant 
defense systems generating H2O as final and secondary oxidants, HO, O2-, and H2O2 as 
intermediate substances. The latter three have very short half-lives and are crucial for 
phagocytic defense of invading microorganisms and intracellular signaling. Concurrently, 
they are able to damage macromolecules due to their high reactivity, when produced in 
excess or ineffectively eliminated. This status is known as oxidative stress (Valko et al., 
2007).  
The most affected targets of ROS are lipids and proteins. Highly abundant and rich in 
reactive groups they take up most of induced damage thus protecting the least durable 
cellular components. Besides, the remaining portion of ROS is still able to cause significant 
harm by oxidizing nucleic acids, in particular DNA, and by impairing the integrity of genetic 
information, which is a prerequisite for many cancers (Pouyssegur et al., 2006).  
Among the various oxidative DNA damages induced by ROS, the oxidation of bases 
is the most prevalent type. The base guanine (G) is particularly susceptible to oxidative 
stress. Due to its low redox potential, many oxidized forms of G are present in the cell. 7,8-
dihydro-8-oxoguanine (8-oxo-G) is a prevalent lesions in the human DNA with an estimated 
steady state level of 103 lesions per cell in normal tissues, and up to 105 lesions per cell in 
cancer tissues (Neeley and Essigmann, 2006). The importance of 8-oxo-G results from its 
high mutagenic potential explained by the incorrect bypass of lesion by replicative DNA 
polymerases (Pols) α, δ, and ε. The incorporation of adenine (A) instead of cytosine (C) 
opposite the lesion is 10 times more frequently performed by replicative Pols, which 
consequently might give rise to the CG->AT transversion mutations if A:8-oxo-G 
mismatches are left unrepaired and possibly leading to various types of cancers (Lange et al., 
2011). 
In unperturbed cells, base excision repair (BER) is the essential pathway to effectively 
combat the mutagenic potential of 8-oxo-G (Zharkov, 2008). The main axis, handling over 
75% of all 8-oxo-G repairs, is initiated by a damage specific glycosylase, 8-oxo-G DNA 
glycosylase (OGG1). Human OGG1 recognizes 8-oxo-G lesions flips the bases out and 
excises them from the DNA, leaving substrates for an endonuclease called 
apurinic/apyrimidinic endonuclease 1 (APE-1). APE-1 generates free bases filled by DNA 
pol β. The 5’ end is trimmed by the dRPlyase activity of DNA pol β and the product finally 
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is ligated by DNA ligase III/XRCC1 (Svilar et al., 2010). If an incorrect adenine (A) is 
incorporated during DNA replication, repair is initiated by the MUTYH glycosylase (MYH) 
that excises, the A opposite the 8-oxo-G lesion, while APE-1 incises the DNA. Then DNA 
pol λ incorporates the correct C and performs strand displacement by one base. Finally, the 
flap endonuclease 1 removes the one nucleotide flap and DNA ligase I seals the DNA thus 
preventing replication errors introduced by 8-oxo-G in duplicating cells (van Loon and 
Hubscher, 2009).  
Nevertheless, repair of oxidative lesions via BER is not a simple process. Depending 
on cellular dynamics and extracellular environment, the BER machinery may involve an 
armamentarium of up to 30 different proteins assisting its function (Mitra et al., 2002). 
Therefore, a subtle regulation of BER proteins is an issue arising from its complexity. The 
essential nature of BER in this aspect urges a cell to keep its components active only when 
needed in order to guarantee the genomic stability required to prevent cancer (Maynard et 
al., 2009).  
The most important cellular condition that requires the adjustment of BER activity is 
oxidative stress. The inability of cells to couple with the excess of ROS can consequently 
lead to oxidative damage. Almost 80% of intracellular ROS are generated through oxidative 
phosphorylation, which is driven by partial O2 reduction in mitochondria, thus shifts in O2 
availability and consumption are the primary cause of oxidative stress under physiological 
conditions. This is the reason why all eukaryotic organisms maintain an oxygen homeostasis. 
Apart from some exceptions, most of human tissues optimally function in O2 concentrations 
that do not exceed 9%, but also do not go below 2%. Both of them – the higher tissue 
oxygenation (hyperoxia) or shortages of O2 supply (hypoxia) – are conditions of stress 
(Semenza, 2010). At the cellular level, the family of the hypoxia inducible transcription 
factors (HIF) is the main mediator of O2 adaptation. The stabilization of HIFs under hypoxia 
activates transcription of downstream genes and exhibits cell protective effects, until O2 
supply is restored (Semenza, 2007). On the other hand, mechanisms to protect and repair the 
DNA of a cell working at higher O2 concentrations, like BER, are still poorly understood 
(van Loon et al., 2010).  
Unfortunately our current knowledge of the regulation of BER genes, depending on tissue 
oxygenation, is still limited to occasional findings that might suggest a link between BER 
genes and O2 in general. Hence, the activity of DNA pol ζ has been reported to be important 
for cultured mouse fibroblasts at a reduced oxygen concentration (2%) which is believed to 
partially mimic conditions of embryonic development (Lange et al., 2012). At the same time, 
exposure of spheroid culture of human skin fibroblasts at different O2 concentrations, to a 
low dose of ionizing radiation (IR) identified BER genes among induced targets (von 
Neubeck et al., 2012). Earlier reports trying to elucidate cellular functions of DNA pol ι 
revealed its dependence on HIF-1α activity (Ito et al., 2006). In addition, overexpression of 
several BER genes has been detected in 30% of 70 cases representing 15 major human 
cancers (Albertella et al., 2005), including metastatic melanoma cells (Sarasin and 
Kauffmann, 2008). This tumor has been well known for its hypoxic microenvironment 
(Pouyssegur et al., 2006), which is also reported to correlate with its treatment resistance 
(Wirthner et al., 2008). In summary, these findings have urged us to carefully investigate the 
regulation of BER genes depending on oxygenation, in non-transformed and tumor cells and 
tissues, focusing not only on its mechanistic insights but also on the biological effects. We 
demonstrate that the shift in tissue oxygenation (O2 switch) activates expression of core BER 
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genes leading to an elevated BER functionality, which is dependent on signaling through 
HIF, but not on the content of oxidative DNA lesions and/or production of ROS. Increased 
BER capacity permits excessive stress tolerance by primary and tumor cells promoting their 
survival. Finally, activation of BER in solid tumors also determines their resistance to anti-
cancer therapies. 
 
Results 
 
O2 switching activates base excision repair proteins via the HIF and the mTOR 
pathways. 
In order to analyze the expression of BER genes in response to different 
concentrations of O2, we probed MRC5 human fetal fibroblasts (Jacobs et al., 1970), as a cell 
line that closely represents physiology of non-transformed cells, for mRNA and protein 
levels of the 5 core BER genes – DNA pol λ (POLL), DNA pol β (POLB), hOGG1, 
MUTYH and Ape-1 (Fig. 1 and Fig. S1). mRNA levels of POLB and hOGG1 were 
increased 6.6-fold and 3.7-fold respectively, remained significantly elevated, and gradually 
declined for the next 120 minutes, following exposure to 0.2% O2 for 16 hours. At the same 
time, mRNA levels of other genes were not affected, except the two hypoxia markers – 
glucose transporter 1 (GLUT1) and carbonic anhydrase 9 (CAIX) (Hoskin et al., 2003), 
increasing under hypoxic conditioning raised 8.7 and 13.8-fold, respectively. GLUT1 and 
CAIX levels returned to basal after 120 min of re-oxygenation (Fig.1, A). Similarly, the 
levels of hOGG1 and POLB have been found to be significantly (2.5- and 8.1-fold, 
respectively) elevated during hypoxia, but in contrast to the mRNA pool, the increased 
protein level of POLB was not maintained during the re-oxygenation phase (Fig. 1, B and 
C), suggesting its primary transcriptional regulation in addition to proteasome dependent 
degradation (Wimmer et al., 2008). Remarkably, the expression of MUTYH and APE-1 
were not changed as could be expected from its crucial importance for replicative cells, and 
for the lesion independent removal of glycosylase processed bases. In addition, the protein 
levels of POLL were also boosted by hypoxia (Fig. 1, B and C), suggesting its regulation to 
be translational in addition to the post-translational modifications recently described by our 
laboratory (Markkanen et al., 2012). Since we initially analyzed the expression of core BER 
genes under stress conditions, we also were curious to see the effects of more physiological 
oxygen changes, e.g. from 5% to 1%. No differences to the pattern of expression of core 
BER genes discovered before could be observed. However, the modulation of expression in 
this case was less pronounced, but still remaining distinctive (Fig. S1, A). In addition, the 
expression of VEGF, bFGF, TGF- and GLUT1, that are a part of tissue adaptation to 
hypoxia, was stimulated by hypoxia under these conditions (Fig. S1, B).  
These various responses of BER genes to hypoxia and re-oxygenation prompted us to 
look closer at possible regulators. HIF-1α has been identified as the primary transcription 
factor driving hypoxic responses and regulates, besides DNA repair genes, the expression of 
over 300 other genes. HIF-1 binds to hypoxia response elements in promoters or enhancers 
of target genes and induces their transcription (Wenger et al., 2005). By using an in silico 
approach (Fig. S1, C) we identified putative HREs in promoters of hOGG1 and POLB genes, 
but not in the promoters of other BER genes and the control genes (Fig. S1, D). The 
functional ability of HREs to stimulate gene transcription was demonstrated by reporter gene 
assay using constructs carrying mutated or wild type HRE sequences (Fig. S1, E). To test 
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whether the HIF pathway can also regulate BER genes ex vivo, we designed short-hairpin 
RNA (shRNA) constructs and transfected HEK293 cells to produce cell lines with stable 
HIF-1α or HIF-2α knock-down. Subjected to hypoxia, cells with down-regulated HIF-1α 
were unable either to induce mRNA (Fig. 1, D) and protein (Fig. 1, E) levels of hOGG1 and 
POLB or to maintain them during re-oxygenation. This was in contrast to parental HEK293 
cells and cells with down-regulated HIF-2α. On the other hand, the expression of other BER 
genes was affected by either of the two HIF isoforms under hypoxia, which was also 
experimentally controlled by evaluating expression of the two hypoxia markers (GLUT1 and 
CAIX) and the HIF factors (Fig. 1, D and E). Since protein levels of POLL were HIF 
independently induced under hypoxia (unpublished data), we next probed the mammalian 
target of rapamycin (mTOR) kinase (Fahling, 2009), a second major modulator of gene 
expression under hypoxia, for its effect on POLL gene expression. The activated mTOR 
kinase is known to interfere positively with the translation of downstream target proteins, 
and can be specifically inhibited by rapamycin and by the cell density (Limoli et al., 2004). 
To avoid a possible influence of HIF-1α, we treated HEK293 cells stably transfected by 
shRNA HIF-1α with rapamycin (Fig. S1, G) or plated the cells at defined densities (Fig. S1, 
H). In both cases elevated protein levels of POLL under hypoxia were observed, while 
protein levels of MUTYH were not affected and as a positive control the levels of 
phosphorylated p70S6K kinase, the downstream target of mTOR, was activated by this 
treatment. At the same time mRNA levels of POLL and MUTYH were not changed due to 
rapamycin treatment, excluding a possible transcriptional effect (Fig. S1, F). 
Taking into account that BER is an orchestra of enzymatic reactions, we next asked 
whether changes in the expression of BER genes induced by differential exposure to O2 have 
consequences on BER functions. To do this we used hairpin oligonucleotides previously 
designed in our laboratory (van Loon and Hubscher, 2009) (Fig. 1, F) that mimic different 
situations of 8-oxo-G repair (Fig. 1, G). The MUTYH - POLL axis of BER was active under 
hypoxia, as detected by the increased [α-P32] dCTP incorporation for substrate 1 (S1), 
however under re-oxygenation conditions, and at the beginning of incubation, such activity 
could not be detected (Fig. 1, H) In contrast, the hOGG1 - POLB mediated BER was 
elevated at the beginning of incubation, and even more under hypoxia and during re-
oxygenation, as detected by the increased [α-P32] dGTP incorporation for substrate 2 (S2) 
(Fig. 1, H). Furthermore, the activity of hOGG1 - POLB mediated BER was dependent on 
HIF-1α as detected by 10-fold reduced [α-P32] dGTP incorporation for S2 when whole cell 
lysates of HEK293 cells transfected with HIF-1α shRNA were used (Fig. 1, I). Up-regulated 
expression of hOGG1 and POLB in this case controls adjustment of the oxidative DNA 
repair capacity depending on the O2 availability, while MUTYH – POLL maintains BER 
under prolonged or chronic hypoxia, known to generate additional amounts of ROS.  
 
The activation of base excision repair genes relies on hypoxia but neither on the extent 
of ROS production nor on the accumulation of oxidative DNA lesions.  
As a next step, we tried to understand how hypoxia and re-oxygenation influences 
ROS production and accumulation of oxidative damage, and how the latter affects the 
expression of BER genes. To address this, rates of intracellular ROS formation in cells 
exposed to different O2 concentrations were determined through dichlorofluorescein (DCF) 
oxidation (Fig. 2, A). We observed an over 3-fold reduced rate of ROS formation after 16 
hours of hypoxic incubation as compared to the rates measured in cells cultured at 20% O2. 
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ROS formation reverted during 120 min of re-oxygenation and increased 6-fold (Fig. 2, B) to 
levels comparable to those induced by 1 mM H2O2 treatment (Fig. S2, A). The accelerated 
ROS formation was also inhibited under reductive conditions of 1 mM dithiothreitol (DTT) 
(Fig. S2, A). 
The dependence of ROS formation on O2 concentration almost mirrored the content of 
8-oxo-G in the DNA, which was assessed first by immunofluorescence (Fig. 2, C), second 
confirmed by flow cytometry (Fig. S2, B) and third observed by Southern hybridization 
combined with immunoblot detection of 8-oxo-G lesions using a specific antibody (Figure 
S2, C). The accumulation of 8-oxo-G in DNA was found to be 2-fold lower in hypoxia as 
compared to re-oxygenated or cells cultured in 20% O2 (Fig. 2, D), suggesting the induction 
and the accumulation of oxidative lesions to be in linear dependence to O2 availability. 
Remarkably, 8-oxo-G mainly accumulated in the cytoplasm during re-oxygenation and 
before start of hypoxic incubation. This is in contrast to its nuclear accumulation upon the 
treatment with chemical oxidants like H2O2. Furthermore, by using a MitoTracker® probe, 
8-oxo-G was also partially localized to mitochondria in the cell (Fig. S2, D), suggesting a 
possible role of mitochondrial damage in the regulation of BER function.  
This finding was in contrast to the previously observed activation of BER genes, since 
rather reduced than elevated expression levels of BER genes under hypoxia might be 
expected. We therefore next addressed whether the content of oxidative lesions in DNA, - 
like 8-oxo-G or signaling via HIF-1α, - is a primary and sufficient event or if their 
combination is required to modulate expression of BER genes accordingly to O2 availability. 
To test this we treated cells with dimethyloxalylglycine (DMOG), a potent inhibitor of 
prolyl-4-hydroxylation-dependent degradation of HIF-1α, mimicking hypoxia (Asikainen et 
al., 2005). Applying DMOG we aimed to activate HIF signaling without interfering with 
accumulation of oxidative DNA damage. Indeed, treatment of cells with 1 mM DMOG for 
16 hours induced mRNA (Fig. 2, E) as well as protein levels (Fig. 2, F and G) of HIF-1α 
target genes under 20% O2 but with no changes in the 8-oxo-G content between DMOG 
treated and control cells (Fig. 2, H, left quadrant). Application of 1 mM DMOG also resulted 
in HIF-1α accumulation (Fig. 2, H) indicating response to hypoxia, as also documented in 
the activation of the CAIX gene (Fig. S2, E). At the same time, as expected, expression of 
the HIF independent BER genes, POLL and MUTYH, was not affected by DMOG treatment 
(Fig. 2, G and Fig. S2, F). In summary, these data suggest that activation of core BER genes 
relies on HIF signaling rather than on accumulation of oxidative lesions.  
 
Activation of base excision repair genes leads to an increased cell survival in response 
to the oxidative stress 
A crucial part of our study was to relate the hypoxia activated expression of BER 
genes to its biological role, since the activation of energy demanding machinery under 
unfavorable conditions is deadly to a cell unless it is absolutely required. It has been reported 
that some BER genes are important for accelerated tissue growth and proper embryonic 
development (Ufer et al., 2010). Other DNA repair factors have been assumed to be 
associated with the ability of hypoxic tumors to resist therapy, that is the cause of over 70% 
of all anti-cancer treatment failures (Zhou et al., 2006). In this context we checked whether 
the activation of BER genes under hypoxia might bring a survival advantage to the cells. 
Using colony formation assays (CFA), we observed that the amount of colonies formed 7 
days after treatment of hypoxic cells or cells cultured at 20% O2 with 1 mM H2O2 for the last 
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2 of 16 hours of incubation were not significantly different (Fig. S3, A), indicating that 
hypoxic cells are not more tolerant to DNA damaging agents than normoxic cells. In 
contrast, when H2O2 was applied during 120 min of re-oxygenation, only cells previously 
subjected to hypoxia and activated BER machinery, were able to form a significant number 
of colonies compared to control cells that were kept constantly at 20% O2 (Fig. 3, A). The 
ability of cells to tolerate excessive stress after the re-oxygenation was not limited to H2O2 
but also to 100 nM methyl methanesulfonate (MMS) (Fig. S3, B) treatment or γ-irradiation 
with a single dose of 3 Gy (Fig. S3, C). The sequential silencing of core BER genes by 
specific siRNA identified hOGG1 and POLB genes to be necessary for cells to exhibit 
protective effects of the activated BER (Fig, 3, C-F). In order to exclude a possible effect of 
the cellular anti-oxidant defense systems on cell survival during re-oxygenation, we tested 
the enzymatic activity and protein levels of the two key detoxifying enzymes catalase (Fig. 
S3, E and F) and GSH peroxidase (Fig. S3, E and G-I). Neither the protein levels nor their 
catalytic activities were affected by hypoxic preconditioning. In addition, there was only a 
moderate change in mitochondrial metabolism as measured by the MTT assay (Fig. S3, D). 
In summary, these data suggest that hypoxic preconditioning activates the expression and 
function of core BER genes, which in turn provide cells with the ability to tolerate excessive 
oxidative stress, thus promoting survival. 
 
Activated base excision repair genes can be identified in dog tumors  
As mentioned above, certain BER genes were identified to be up-regulated in tumors 
(Albertella et al., 2005). The main pitfall of these previously published studies was lack of 
healthy tissue controls while analyzing BER genes in tumors. In order to address this 
question, we examined matched tumor and healthy tissue biopsies from dogs with 
spontaneous tumors. This allowed us to precisely estimate mRNA and protein levels for the 
five core BER genes (hOGG1, MUTYH, APE1, POLB and POLL). We tested eight biopsy 
pairs of canine non-Hodgkin, non-metastatic stage IIB lymphoma (NHL, stage IIB), for the 
expression of the five core BER genes in correlation to the average content of CD20+ B-cells 
(Fig. S4, D) in order to exclude stromal influences. We found that mRNA levels of hOGG1 
and POLB were significantly increased in tumor cells as compared to the healthy match, and 
their expression has been also correlated to the expression of two tumor hypoxia marker 
genes – DEC1 and CAIX (Zhang and Li, 2007) (Fig. 4, A). At the same time, protein levels 
of all studied BER genes and both tumor hypoxia markers were significantly increased in 
NHL IIB cells (Fig. 4, B and C). These observations were cell type independent and a similar 
expression pattern was found also in three matching biopsies of another canine tumor, 
namely malignant fibrotic liposarcoma (FLS) with comparable staging (Fig. S4, A-C). 
Surprisingly, in spite of a low population number, the frequency of tumor samples with 
overexpressed BER genes was as high as 100%, in contrast to the previous reports showing 
the average frequency at 30%. Using an in vitro BER assay we also detected elevated BER 
activity in tumors, both for MUTYH and hOGG1 initiated repair, as seen from over 8-fold 
increased incorporation of [α-P32] dCTP on S1, and [α-P32] dGTP on S2, respectively (Fig. 4, 
D). Next, we revived NHL IIB samples to obtain B-cells in culture and evaluated their 
survival potential by CFA. Both revived tumor B-cells and non-transformed splenic 
lymphocytes were able to tolerate oxidative stress upon re-oxygenation, as shown by 
increased number of colonies formed following treatment with DNA damaging agents (Fig. 
4, E). Moreover, survival of re-oxygenated tumor cells was even higher than cells derived 
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from matching healthy tissue exposed to hypoxia. Similarly to primary cells, both healthy 
tissue and tumor derived B-lymphocytes, required unperturbed hOGG1 and POLB function 
in order to maintain the cell protective effects (Fig. 4, F-G), suggesting a similar mechanism 
of BER activation to be used also by tumors to tolerate excessive stress and to contribute to 
treatment resistance.  
 
Discussion  
 
O2 availability and consumption have long been expected to be a driving force to 
regulate the expression and function of oxidative DNA repair genes. The rationale behind 
this is based on data generated in our and other laboratories on the function of BER proteins 
under oxidative stress conditions. Oxidative stress has been associated with increased 
oxidative damage to DNA and elevated expression of BER genes (van Loon and Hubscher, 
2009). As a byproduct of O2 reduction in mitochondria, ROS production has also been 
reported to be in a linear dependence to O2 utilization and the metabolic activity of a cell 
(Dirmeier et al., 2004). As a consequence, a linear relationship between ROS formation and 
expression of BER genes had also been expected since oxidative lesions are direct substrates 
of core genes in the BER pathway. Based on these data we initially hypothesized that an 
increase in tissue O2 partial pressure should lead to increased formation of ROS, cause 
additional oxidative DNA damage and finally would elevate the expression of BER genes in 
order to repair the increased oxidative lesion burden. On the contrary, an O2 shortage should 
lead to reduced expression of BER genes due to basal or even lowered ROS formation and 
thus oxidative DNA damage.  
To our surprise, the expression of the two core BER enzymes - hOGG1 and DNA pol 
β gene was simultaneously and significantly up-regulated under hypoxia and, even more 
remarkable, - maintained for 120 minutes upon re-oxygenation. Acting in short-patch BER 
hOGG1 and DNA pol β control the levels of 8-oxo-G in the cell (Frosina et al., 1996). Their 
activation leads to elevated DNA repair capacity, unnecessary under hypoxia, especially 
from the point of limited energy resources and low level of oxidative DNA damage, but is 
required later as demonstrated, to exhibit a protective effect against prospective oxidative 
stress caused by re-oxygenation. This mirrors a situation that often occurs in different tissues 
in the body as well as during embryonic development. At the same time, the expression of 
Ape-1, or MUTYH, which together with DNA pol λ forms back up loop for error-free 8-oxo-
G bypass in replicating cells (van Loon and Hubscher, 2009), remains unaffected. This 
finding is supportive for their “guardian mission” in oxidative DNA repair, as perturbation in 
either expression or activity of these genes leads to multiple pathological conditions 
(Sampson et al., 2005) (Ohba et al., 2009). The difference between our current and previous 
findings consists in how oxidative stress was induced. In the present study we focused on 
physiological induction of oxidative stress by hypoxic modulation of ROS production. In 
most previous reports chemical oxidants, like H2O2, or other drugs, e.g. menadion, were used 
to cause cellular stress. In our opinion, this explains not only the least pronounced changes in 
8-oxo-G induction under oxidative stress (e.g. as compared to H2O2 treatment), but also 
previously unreported alterations of expression pattern of BER genes observed under 
physiological conditions.   
Uncoupling expression of BER genes from the rate of ROS production or content of 
oxidative lesions in the cell is another novel finding of our study. Expression of BER genes 
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is expected to correlate with the amount of 8-oxo-G in cellular DNA since increase in 8-oxo-
G content requires to be handled by an additional quantity of BER proteins. Technical 
limitations did not allow us to analyze all BER genes, but only HIF-1 dependent members, 
the expression of which was increased after treatment with DMOG that interferes with HIF-
1α stability without affecting 8-oxo-G content in DNA. The HIF-1α pathway has been 
reported earlier to regulate the expression of DNA pol , a member of Y family of DNA pols 
and being another translesion synthesis (TLS) enzyme (Ito et al., 2006). TLS by DNA pol ι is 
error-prone thus its involvement in BER is observed mainly under pathological conditions, 
such as in cancer, where the functions of the core BER genes are often impaired (Lange et 
al., 2011). The HIF family of transcription factors is known to control many genes involved 
in adaptation to O2 (Wenger et al., 2005). The list of its downstream targets is still 
continuously growing. Our work includes now also DNA pol β and hOGG1 as downstream 
targets of HIF. Interestingly, the hypoxia-inducible DNA pol λ, the other of two (along to 
DNA pol β) X family members, is a downstream target of the mTOR kinase, the function of 
which is linked to active cell growth, autophagy as well as to several pathologies. These 
events all involve oxidative stress (Sengupta et al., 2010). Distinct pathways controlling key 
BER DNA pols might be advantageous when extended BER function is needed. Along this 
line, we note that up-regulation of BER genes by both of these mechanisms resulted in 
elevated repair capacity of a cell. Although down-regulation of hOGG1 and DNA pol β by 
specific siRNA supported for direct involvement of absolute protein levels, it still remains 
unclear whether enzymatic activities of these proteins are also needs to be modified to 
exhibit cell protective effect since our recent developments demonstrate a critical role of 
post-translational modifications for the function of other core BER proteins, MUTYH and 
DNA pol  (Markkanen et al., 2012).  
The data presented in this work allows us to explain not only why the expression of 
BER genes is activated under non-favorable conditions, but also the possible benefits and 
biological consequences (Figure 5). Large hypoxic areas characterize the vast majority of 
tumors in mammals (Lehmann et al., 2009) (Matsumoto et al., 2010) and the severity of 
hypoxia predicts resistance to chemo- and radiation therapy (Zhou et al., 2006). Along this 
line we decided to test our finding, using dogs, bearing spontaneously occurring tumors, as a 
model that closely represents tumor initiation and progress in humans (Khanna et al., 2006). 
We detected several tumor types with over-expression of both hypoxia markers and BER 
genes. We therefore assume that activated BER can contribute to survival of hypoxic cells. 
However, treated with multiple DNA damaging agents, including MMS or γ-irradiation, both 
primary or revived hypoxic tumor cells were not able to tolerate DNA damage. In contrast to 
the situation when damaging agents were applied at later time point during re-oxygenation 
and were expected to cause even more cellular stress, they were tolerated to a large extent, 
including γ-irradiation. As it has been reported for some cases of drug resistance (Valko et 
al., 2006), in our study, increased protein levels or elevated enzymatic activity of detoxifying 
enzymes was not detected. Therefore activation of BER in this case is the only mechanism 
that allows for excessive oxidative stress tolerance, which in a way is the same for primary 
cells or tumor cells from dogs, points for an universality of our findings. Furthermore, 
activity of BER in either NHL IIB samples, or FLS sample was elevated and dependent on 
the level of BER genes expression thus making hyperfunction of BER to be one of the 
factors in tumor treatment resistance. Our data are independently supported in a study where 
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human colon cancer biopsies were compared to surrounding healthy tissues (Kirkali et al., 
2011).   
The forces of BER activation in vivo are still awaiting further elucidation. In this 
direction, multiple reports highlight the importance of tissue O2 dynamics. Impressively, the 
dynamics of perfusion and O2 persistence in the tissue ranges from just 20 milliseconds, in 
mouse brain under stress (Shen et al., 2009), to many days in a developing human embryo 
(Dunwoodie, 2009). Tumor tissue known for its chaotic vascularization is an excellent 
example. A high rate of cell proliferation in addition to dysfunctional perfusion constantly 
induce intermittent hypoxia in the growing tumor mass (Matsumoto et al., 2010), thereby 
activating BER genes. Finally, the littoral crab (Carcinus maenas), which can dive up to 40 
meters deep and returns back to sea level, is repeatedly exposed to O2 concentrations 
between 0.01% and 20% for at least 30 times a day known for its high stress tolerance 
(Taylor, 1976). Conclusively, the mentioned processes would all be deleterious for living 
cells and organisms due to increased ROS production and high rate of oxidative DNA 
damage unless a general mechanism to combat that danger would exist as an “insurance” and 
can be adjusted accordingly to potential needs to sudden changes in the environment or in 
the body. Such changes in the body can be physiological as well as pathological (e.g. cancer 
microenvironment). 
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Experimental procedures 
 
Chemicals 
Deoxyribonucleoside triphphosphates were purchased from Sigma. Labeled [α-32P] dGTP 
and [α-32P] dCTP were purchased from Hartmann Analytic (Germany). All other reagents 
were of analytic grade and purchased from Fluka, Sigma or Merck. Microsynth synthesized 
the oligonucleotides, and 3’-biotinylated 58-mer were from Purimex. Streptavidin-coupled 
magnetic beads (Cat. #112.05D) were purchased from Invitrogen Dynal AG (Oslo, Norway). 
 
Cell cultures 
All cells were maintained under 95% air/5% CO2 in DMEM supplemented with 15% FBS, 
penicillin (100 U/ml) and streptomycin (100 μg/ml). For hypoxia and subsequent re-
oxygenation cells were grown and passaged in a gas-controlled glove box to handle the cells 
under constant oxygen (InvivO2 400, Ruskinn Technologies, Leeds, UK) using reagents pre-
equilibrated to the oxygen concentration in the glove box. All cell culture reagents were 
purchased from Invitrogen (Carlsbad, CA, USA). 
 
Reverse transcription quantitative RT-PCR  
Total RNA was extracted using TRIzol® reagent (Cat. #15596-026, Invitrogen, CA, USA) 
accordingly to the manufacturer’s instructions. After treatment with DNase I (Cat. #776785, 
Roche Diagnostics, Mannheim, Germany), fraction of messenger RNA (mRNA) was 
precipitated by addition of LiCl to 2.5 M at -20 0C and 3 μg of mRNA was used in 
Superscript III (Cat. #18080-044, Invitrogen, Basel, Switzerland) reverse transcription (RT) 
accordingly to the producer’s protocol. Messenger RNA levels were quantified with 5% of 
the diluted complementary DNA reaction mix by quantitative polymerase chain reaction 
(qPCR) using gene specific primers (Table S1) and SensiMixPlus SYBR kit (Cat. #QT-605-
02, Quantace Ltd., UK) in combination with a Rotor Gene RG-3000A light cycler (Corbett 
Research, QIAGEN, Germany). Initial template concentrations of each sample were 
calculated by comparison with serial dilutions of a calibrated standard. To control for equal 
input levels, ribosomal protein L28 (RPL28) mRNA was determined and data expressed as 
ratios relative to L28 levels. Melting point analyses of amplified PCR products were 
performed after each run to verify specific amplification. 
 
Protein extractions and immunoblot analyses 
Cells were washed twice and scraped into ice-cold PBS. For BER and enzymatic assays 
cellular proteins were extracted with a high-salt buffer containing 0.5% NP-40 and protein 
concentrations were determined by the Bradford method as described before (Wimmer et al., 
2008). Alternatively, total cell lysates were prepared to analyze protein levels. Therefore, 
cells were collected in ice-cold PBS, lysed with 4% sodium dodecylsulfate (SDS), 120 mM 
Tris-HCl (pH 6.8) and 20% glycerol, followed by sonification and boiling for 5 min. In this 
case, protein concentrations were determined using the Lowry assay. Protein (50-80 μg) was 
separated by SDS–polyacrylamide gel electrophoresis, electro-transferred onto 
polyvinylidene difluoride membranes and probed with primary antibodies derived against 
proteins of interest (Table S2). Fluorescence labeled secondary antibodies and Odyssey 
Infrared Imaging System (LI-COR GmbH, Germany) were used to detect and analyze 
signals.  
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Base Excision Repair (BER) Assays 
Repair assays were performed in a reaction mixture (20 μl) containing 50 mM HEPES (pH 
7.4), 20 mM KCl, 2 mM DTT, 10 mM MgCl2, 2 mM ATP, 2 μM 5′[α-32P] 
dGTP/dATP/dCTP (3000 Ci/mmol), and 300 pmol of either substrate DNA. The reactions 
were initiated by adding 10 μg of control or sample whole cell extract, incubated at 37°C for 
30 min and then stopped with 5 µl of 0.25 M EDTA.  
 
Reactive Oxygen Species (ROS) Detection 
Intracellular ROS production was determined by flow cytometry as a rate of DCFH 
oxidation according to Mahfouz et al. with modifications (Mahfouz et al., 2009). Cells were 
washed twice with PBS and incubated with 100 μM of carboxy-H2DCF-DA (Cat. #C-400, 
Molecular Probes, Invitrogen, Basel, Switzerland) at 37°C for 30 min in culture medium 
supplemented with 1% (v/v) FCS, which was substituted for PBS on completion. The DCF 
fluorescence was evaluated between 500 and 530 nm using a flow cytometer equipped with a 
488-nm argon laser as a light source (CyAn ADP Analyzer, Beckman Coulter International 
S.A., Switzerland). Data were expressed as the percentage of fluorescent cells.  
 
Flow Cytometry 
All fluorescence signals of labeled cells were analyzed by the flow cytometer CyAn ADP 
Analyzer (Beckman Coulter International S.A., Switzerland). A minimum of 100,000 cells 
were examined for each assay at a flow rate of <100 cells/second. The cell population was 
gated using 90R° and forward-angle light scatter to exclude debris and aggregates. The 
excitation wavelength was 488 nm supplied by an argon laser at 15 mW. The percentage of 
positive cells and the mean fluorescence were calculated on a 1023-channel scale and 
analyzed using the Summit Software (Beckman Coulter International S.A., Switzerland). 
 
Immunofluorescence 
104 cells were seeded on 60 mm dishes containing 10 mm glass cover slips. Following 
treatment cells were rinsed with PBS and fixed with 100% methanol at -30°C for 10 min. 
After blocking with 10% fetal calf serum for 1 hour, cover slips were moved to 24-well 
plate, the primary antibodies (Table S2) were allowed to bind for 2 hours and immune 
complexes were detected using secondary anti-rabbit Alexa Fluor 488 (Cat. #A-
11008)/Texas Red (Cat. #T-2767) - and anti-mouse Alexa Fluor 488 (Cat. #A-11001)/Texas 
Red (Cat. #T-862) - conjugates, respectively (Molecular Probes, Invitrogen, Basel, 
Switzerland). Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI). Glass cover 
slips were dried for 30 min and mounted in DPX (Cat. #44587, Sigma, Buchs, Switzerland) 
in the dark. Epifluorescence was analyzed using an Olympus BX51 microscopy system 
(Olympus, Volketswil, Switzerland) and images were captured with fixed exposure times. 
 
Colony formation assays 
1*105 cells were cultured on 100 mm tissue culture plates for 24 hours exposed to different 
oxygen conditions (see Cell cultures) for 16 hours and subsequently treated with 1 mM H2O2 
(Cat. #H1009, Sigma, Buchs, Switzerland) for the last 2 hours of incubation, or during re-
oxygenation. Cells were then trypsinized, counted and 103 cells seeded on 60 mm culture 
plates and grown for an additional 7 days. Following fixation with 6% glutaraldehyde in 
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phosphate-buffered saline (PBS), the colonies were stained with crystal violet, counted and 
the numbers normalized to the untreated control groups.  
 
RNA interference 
MRC5 cells were plated at a density of 3x105 cells per 60 mm culture plate and allowed to 
adhere overnight and then transfected with 100 pmol of small interfering RNA (siRNA) 
targeting POLL (Qiagen ID 9), POLB (Qiagen ID 12), MUTYH (Qiagen ID 11) or 
hOGG1/2 (Cat. #SC-43983, Santa Cruz Biotechnology, CA, USA) genes using 
Lipofectamine RNAiMAX (Cat. #13778-150, Invitrogen, Basel, Switzerland) according to 
the manufacturer’s protocol. Following 48 hours, cells were processed as required for 
subsequent procedures.  
 
HIF-α knockdown cells and lentiviral infections  
HEK293 shHIF1α clones were generated by transfection with a pLKO.1-puro vector 
expressing U6 promoter driven shRNA-targeting nucleotides 1168-1188 of human HIF-1α 
(NM_001530.x-1048s1c1, Sigma). Cell clones were derived by puromycin selection (2 
μg/ml) and ring cloning. Lentiviral expression vectors encoding three shRNA sequences 
targeting human HIF-2α at nucleotides 878-898 (#1, NM_001430.x-517s1c1), 927-947 (#5, 
NM_001430.x-566s1c1) and 2055-2075 (#4, NM_001430.x-1694s1c1) in a pLKO.1-puro 
plasmid were purchased from Sigma. Viral particles were produced in HEK293T cells by co-
transfection of the respective transfer vector (3 μg) with the packaging plasmids pLP1 (4.2 
μg), pLP2 (2 μg) and pVSV-G (2.8 μg, all from Invitrogen) using PEI transfection as 
described before (Stiehl et al., 2006) HEK293 cells were infected with lentiviral-pseudo 
typed particles and cell pools were derived by puromycin (2 μg/ml) selection. 
 
Statistical Analysis 
Statistical analyses were carried out by one-way ANOVA with post-Tukey multiple 
comparison test using the XLSTAT®-Pro 2011 statistical analysis add-on for Microsoft® 
Excel® (SAS Institute Inc., NC, USA). All tests were two-sided with statistical significance 
set at p < 0.05(**).  
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Figure legends 
 
Figure 1. Hypoxia activates BER via multiple pathways. (A) Expression of core BER and 
hypoxia mRNAs in MRC5 cells analyzed by RT-qPCR. Shown are mean values +/- SEMs of 
five independent experiments. (B) Expression of core BER and hypoxia proteins in MRC5 
cells analyzed by immunoblotting. Median intensity of protein bands was expressed relative 
to β-tubulin control. Shown are mean values +/- SEMs of three independent experiments. 
(C). Quantification of B. (D) Expression of 4 core BER and 3 hypoxia-inducible mRNAs in 
parental (wild type) and HIF-1α/HIF-2α shRNA transfected HEK293 cells analyzed by RT-
qPCR. The cells were analyzed at 20% and 0.2% O2, respectively. (E) Expression of POLB, 
hOGG1 and HIF-1α proteins in parental (wild type) and HIF-1α/HIF-2α shRNA transfected 
HEK293 cells under hypoxia (0.2% O2) analyzed by immunoblotting. (F) Oligonucleotide 
constructs (substrates) used for the in vitro BER assay. (G) Schematic representation of in 
vitro BER assay experiments. For further explanation see text. (H) In vitro BER assay of 
MRC5 cells cultured for 16 hours at the indicated oxygen atmosphere. Shown are mean 
values of incorporation of radioactively labeled deoxynucleoside triphosphates subtracted to 
control +/- SEMs of five independent experiments. (I) In vitro BER assay of parental (wild 
type) and HIF-1α/HIF-2α shRNA transfected HEK293 cells cultured for 16 hours at 
respective oxygen atmosphere. Shown are mean values of incorporation of radioactively 
labeled deoxynucleoside triphosphates subtracted to control +/- SEMs of three experiments.  
 
Figure S1. Hypoxia activates BER via multiple pathways. (A) Expression of POLB, 
hOGG1, MUTYH and GLUT1 mRNAs in MRC5 cells cultured for 16 hours under the 
indicated oxygen atmosphere analyzed by RT-qPCR. Shown are mean values +/- SEMs of 
five independent experiments. (B) mRNA levels of the angiogenesis factors VEGF, bFGF, 
TGF-β, and the hypoxia marker GLUT1 in MRC5 cells cultured for 16 hours under the 
indicated oxygen atmosphere analyzed by RT-qPCR. Shown are mean values +/- SEMs of 
three independent experiments. (C) Schematic representation of in silico predicted hypoxia 
response elements (HREs). (D) HREs identified in the promoter regions of core BER and 
control gene sets. TSS: transcription start site; numbers show the position of the first 
nucleotide in the HRE motif relative to TSS. (E) Reporter gene assay of in silico identified 
HREs in POLB and hOGG1promoter regions. WT: native HRE sequence, mut: HRE 
sequence disrupted for HIF binding site. R.L.U., relative light units. (F) Expression of POLL 
and MUTYH mRNAs in MRC5 cells cultured for 16 hours under the indicated oxygen 
atmosphere and treated with 200 nM rapamycin for the last 2 hours analyzed by RT-qPCR. 
Shown are mean values +/- SEMs of two experiments. (G) Expression of POLL and 
MUTYH proteins in MRC5 cells cultured for 16 hours under the indicated oxygen 
atmosphere and treated with 200 nM rapamycin for the last 2 hours of incubation analyzed 
by immunoblotting. P70S6K expression controlled mTOR activity and β-tubulin was used as 
a loading control. (H) Expression of POLL and MUTYH proteins in MRC5 cells plated at 
different cell density and cultured for 16 hours under the indicated oxygen atmosphere 
analyzed by immunoblotting.  
 
Figure 2. The activation of BER genes relies on hypoxia but not on the extent of ROS 
production or on the accumulation of oxidative DNA lesions. (A) Rates of intracellular 
ROS production in MRC5 cells cultured for 16 hours under the indicated oxygen 
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atmosphere. Percentage of DCF positive cells is indicated. (B) Area under the curve (AUC) 
plotted from three independent experiments described in A. (C) 8-oxo-G accumulation 
analyzed by immunofluorescence with a specific antibody. (D) Mean fluorescence intensity 
of 8-oxo-G calculated for 200 cells +/- SEMs in C. (E) Expression of core BER and hypoxia 
mRNAs in MRC5 cells cultured for 16 hours under the indicated oxygen atmosphere and 
treated with 1 mM DMOG analyzed by RT-qPCR. Shown are mean values +/- SEMs of five 
independent experiments. (F) Expression of core BER and hypoxia proteins in MRC5 cells 
treated with 1 mM DMOG analyzed by immunoblotting. Median intensity of protein bands 
was expressed relative to the β-tubulin control. Shown are mean values +/- SEMs of three 
independent experiments. (G) Quantification of F. (H) Accumulation of 8-oxo-G and 
expression of HIF-1α protein analyzed by immunofluorescence in MRC5 cells cultured for 
16 hours at 20% O2 and treated with 1 mM DMOG. (I) Mean fluorescence intensity 
calculated for 200 cells +/- SEMs is shown. (J) Expression of POLB and hOGG1 proteins 
analyzed by immunofluorescence in MRC5 cells cultured for 16 hours at 20% O2 and treated 
with 1 mM DMOG. (K) Mean fluorescence intensity calculated for 200 cells +/- SEMs is 
shown. 
 
Figure S2. The activation of BER genes relies on hypoxia but not on the extent of ROS 
production or on the accumulation of oxidative DNA lesions. (A) Rates of intracellular 
ROS production in MRC5 cells cultured for 16 hours at 5% oxygen and treated with 1 mM 
H2O2, PBS or 1 mM DTT for the last two hours of incubation. Percentage of DCF positive 
cells is indicated. (B) 8-oxo-G accumulation analyzed by flow cytometry with a specific 
antibody. Percentage of positive cells is indicated. (C) Detection of 8-oxo-G in DNA of 
MRC5 cells by the combined hybridization-immunoblot technique. (D) Co-staining of 8-
oxo-G and MitroTracker® Green, a mitochondria specific probe. (E-F) Expression of POLL 
(E) and CAIX (F) proteins analyzed by immunofluorescence in MRC5 cells cultured for 16 
hours at 20% O2 and treated with 1 mM DMOG. 
 
Figure 3. Activation of BER leads to an increased cell survival in response to the 
oxidative stress. (A) Colony formation assay of MRC5 cells treated with 1 mM H2O2 during 
120 min of re-oxygenation. Shown are mean values +/- SEMs of three experiments. (B) 
Silencing of core BER genes under hypoxia. MRC5 cells were transfected with respective 
siRNA 48 hours prior to the differential oxygenation. (C-F) Colony forming assay of MRC5 
cells with siRNA silenced BER genes (C: POLL, D: POLB, E: OGG1, F: MUTYH) treated 
with 1 mM H2O2 during 120 min of re-oxygenation. Shown are mean values +/- SEMs of 
three experiments. 
 
Figure S3. Activation of BER leads to an increased cell survival in response to the 
oxidative stress. (A) Colony formation assay of MRC5 cells treated with 1 mM H2O2 during 
last 2 hours of hypoxia. (B) Colony formation assay of MRC5 cells treated with 100 nM 
MMS during 120 minutes of re-oxygenation. (C) Colony formation assay of MRC5 cells 
treated with 3 Gy of γ-irradiation during 120 minutes of re-oxygenation. Shown are mean 
values +/- SEMs of three independent experiments (A, B and C)  (D) MTT assay of MRC5 
cells treated with 1 mM H2O2, 100 nM MMS and 3 Gy of γ-irradiation during 120 minutes 
of re-oxygenation. Cells were allowed to recover for 24 hours after treatment. Mean values 
+/- SEMs of five independent experiments are shown. (E) Expression of catalase and GSH 
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peroxidase proteins in MRC5 cells analyzed by immunoblotting. (F) Activity of catalase in 
MRC5 cells treated with 1 mM H2O2 for 120 minutes of re-oxygenation analyzed in an in 
vitro assay using whole cell extracts. Arrowed labels represent treatment with 100 nM MMS. 
(G-I) Activity of GSH peroxidase in untreated (G), or treated with 1 mM H2O2 (H) or 100 
nM MMS (I) MRC5 cells during 120 minutes of re-oxygenation analyzed by an in vitro 
assay using whole cell protein extracts. Mean values +/- SEMs of a five independent 
experiments are shown (for F-I). 
 
Figure 4. Activated BER genes can be identified in dog tumors. (A) mRNA expression 
levels of core BER and hypoxia-inducible genes in canine NHL samples (n=8) analyzed by 
RT-qPCR. Shown are mean values +/- SEMs. (B) Expression of core BER and hypoxia 
proteins in canine NHL samples (n=8) analyzed by immunoblotting. Median intensity of 
protein bands was expressed relative to β-tubulin control. Shown are mean values +/- SEMs. 
(C) Quantification of B. (D) In vitro BER assay of canine NHL samples (n=8). Shown are 
mean values of incorporation of radioactively labeled deoxyribonucleoside triphosphates 
subtracted to control +/- SEMs. (E) Colony formation assay of revived tumor and matching 
non-transformed B-lymphocytes obtained from NHL samples (n=8) treated with 1 mM H2O2 
during 120 minutes of re-oxygenation. Shown are mean values +/- SEMs. (F) Silencing of 
core BER genes in revived tumor B-lymphocytes under hypoxia. Cells were transfected with 
respective siRNA 48 hours prior to the differential oxygenation. (G-H) Colony forming 
assay of revived tumor and matching non-transformed B-lymphocytes obtained from NHL 
samples (n=8) with siRNA silenced BER genes (G: POLB, H: OGG1) treated with 1 mM 
H2O2 during 120 minutes of re-oxygenation. Shown are mean values +/- SEMs. 
 
Figure S4. Activated BER genes can be identified in dog tumors. (A) Expression of core 
BER and hypoxia mRNAs in canine FLS samples (n=3) analyzed by RT-qPCR. Shown are 
mean values +/- SEMs. (B) Expression of core BER and hypoxia proteins in canine FLS 
samples (n=3) analyzed by immunoblotting. Median intensity of protein bands was 
expressed relative to β-tubulin control. Shown are mean values +/- SEMs. (C) Quantification 
of B. (D) Fractionation of NHL and FLS tumor samples by flow cytometry. Percentage of 
positive cells is indicated, +/- SEM. 
 
Figure 5. Model for regulation of BER proteins leading to subsequent increased 
survival upon hyperoxia. For details see text.  
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Supplemental information 
 
Supplemental Figures and Tables  
 
Table S1. List of oligonucleotide primers used in RT-qPCR (designed with Primer 3 
software: http://frodo.wi.mit.edu/primer3/) 
 
Symbol Accession# Primers (5’->3’) (Start-End) PL, bps 
 
Core BER genes  
 
POLL NM_001174084.1 FW: cctgtgccctgctctacttc 
RV: ctcagcaggttctcggtagg (1994-2211) 
218 
POLB NM_002690.1 FW: gagaagaacgtgagccaagc  
RV: cgtatcatcctgccgaatct (189-392) 
204 
hOGG1 NM_002542.5 FW: gcagcagctacgagagtcct  
RV: ttcccagttccttgttggtc  (1018-1244) 
227 
MUTYH NM_001048171.1 FW: ccagagagtggagcaggaac  
RV: tttctggggaagttgaccac (989-1144) 
156 
APE1 NM_001244249.1 FW: gctgcctggactctctcatc  
RV: gctgttaccagcacaaacga  (662-841) 
180 
 
Hypoxia markers  
 
HIF1α NM_002690.1 FW: gaaagcgcaagtcctcaaag 
RV: tgggtaggagatggagatgc (2175-2341) 
167 
HIF2α NM_001430.4 FW: ttgatgtggaaacggatgaa 
RV: ggaacctgctcttgctgttc (2713-2908) 
196 
CAIX NM_001216.2 FW: taagcagctccacaccctct 
RV: tctcatctgcacaaggaacg (1101-1350) 
250 
DEC1 NM_017418.2 FW: ccttgaagcatgtgaaagca 
RV: gcttggccagatactgaagc (606-785) 
180 
GLUT1 NM_006516.2 FW: cttcactgtcgtgtcgctgt 
RV: tgaagagttcagccacgatg (1482-1711) 
230 
 
Angiogenesis markers   
 
VEGF NM_001025366.2 FW: cccactgaggagtccaacat 
RV: tttcttgcgctttcgttttt (1324-1509) 
186 
bFGF NM_002006.4 FW:	ggtgaaaccccgtctctaca 
RV: tctgttgcctaggctggact (2939-3110) 
172 
TGF-β NM_000660.4 FW: gggactatccacctgcaaga 
RV: cctccttggcgtagtagtc (966-1204) 
239 
 
Reference genes   
RPL28 NM_000991.4 FW: gcaattccttccgctacaac 
RV: tgttcttgcggatcatgtgt (146-343) 
198 
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Table S2. List of primary antibodies  
 
Symbol Entrez-Gene ID/Protein Mw, kDa Cat. # Manufacturer 
 
Core BER genes  
 
POLL 27343, polymerase (DNA directed), 
lambda 
72  Locally raised
POLB 5423, polymerase (DNA directed), 
beta 
38 PA1-23198 Thermo Scientific
hOGG1 4968, 8-oxoguanine DNA glycosylase 39 NB100-106 Novus
MUTYH 4595, mutY homolog (E. coli) 65 sc-30630 Santa Cruz
APE1 328, APEX nuclease (multifunctional 
DNA repair enzyme) 1 
37 sc-5572 Santa Cruz
 
Hypoxia markers  
 
HIF1α 3091, hypoxia inducible factor 1, alpha 
subunit 
120 610958 BD
CAIX 768, carbonic anhydrase IX 58 PA1-16592 Thermo Scientific
DEC1 50514, deleted in esophageal cancer 1 51 A300-649A Betyl
GLUT1 6513, solute carrier family 2, member 
1 
55 NB110-39113 Novus
 
Others 
 
Catalase 847, catalase 59 ab1877 Abcam
GSH-Px 2876, glutathione peroxidase 1 22 ab22604 Abcam
β-tubulin 203068, tubulin, beta class 1 55 T8328 Sigma
P70S6KThr389 6198, RP S6 kinase 70 9205 Cell Signaling
8-oxo-G  MAB3560 Millipore
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Supplemental Experimental Procedures 
 
In silico identification of hypoxia responsive elements 
Identification of hypoxia responsive elements (HRE) in promoters of base excision repair 
genes was performed as described in (Qiu et al., 2003) with modifications. Gene IDs along 
with sequence information were retrieved from NCBI Gene 
(http://www.ncbi.nlm.nih.gov/gene/) and the eukaryotic promoter database (EPD, 
http://epd.vital-it.ch/) was used to extract promoter sequences (identified promoters), or 
alternatively, 10 kbps 5’- upstream sequences were obtained from Genatlas 
(http://genatlas.medecine.univ-paris5.fr/) and processed by BDGB (http://www.fruitfly.org/) 
and Pro Scan (http://bimas.dcrt.nih.gov/molbio/) network for promoter prediction (unknown 
promoters). Signal Scan (http://bimas.dcrt.nih.gov/molbio/) analyzed extracted and predicted 
promoter sequences. 
 
Reporter gene assay 
The assay for reporter gene was performed as described in (Wollenick et al., 2011) with 
minor modifications. Plasmid vectors provided by these authors were digested with Mlu1 
and Xho1 and ligated to either wild-type POLB (5’ – 
cgcgtCCGCCCCGCCCAGGACGCGTGACGTCACAACAACGCc – 3’, 3’ – 
tcgagGCGTTGTTGTGACGTCACGCGTCCTGGGCGGGGCGGa – 5’) and hOGG1 (5’ –	
cgcgtAACGGGCTGGGGAAGGACGTGGCTCTGAAG 
ACGGACc – 3’, 3’ – tcgagGTCCGTCTTCAGAGCCACGTCCTTCCCCA 
GCCCGTTa – 5’) or mutant POLB (5’ – cgcgtCCGCCCCGCCCAGGACtat 
caACGTCACAACAACGCc – 3’, 3’ – tcgagGCGTTGTTGTGACGTtgataG 
TCCTGGGCGGGGCGGa – 5’) and hOGG1 (5’ –	cgcgtAACGGGCTGGG 
GAAGGtatcaGCTCTGAAGACGGACc – 3’, 3’ – tcgagGTCCGTCTTCAG 
AGCtgataCCTTCCCCAGCCCGTTa – 5’) synthetic oligonucleotides, representing 
respective gene promoters with intact (WT) or disrupted (mut) HRE. Transfections for 
reporter gene experiments were carried out on 100 mm culture plates, 293 cells were co- 
transfected with 3 μg reporter plasmid or a mix of 1.5 μg reporter and 1.5 μg expression 
plasmids, respectively. The transfection efficiency was controlled by co-transfection of 30 ng 
pEGFP-C2 (Clontech).  
 
Isolation and culture of cells from dog tumors and tissues 
Tumor and non-transformed cells were isolated from excised tissues of dogs undergoing 
surgery as described in (Quero et al., 2011) with modifications. Briefly, tissue samples were 
washed twice with ice cold PBS and homogenized in the sterile 0.3% collagenase NB4 (Cat. 
#17454, Serva, Switzerland) and 0.2% dispase II (Cat. #04942078001, Roche Diagnostics, 
Switzerland) in PBS for several hours. The cells were filtered through a 70 µm cell strainer 
(BD Bioscience, Switzerland) and expanded in monolayer culture system containing 
DMEM/F12 (Sigma, Switzerland) media with 10% FCS (Cat. #S0400-500, BioWest, 
Switzerland), penicillin (50 U/ml), streptomycin (50 µg/ml), and ampicillin (125 ng/ml) 
(Invitrogen, Switzerland). Medium was changed twice a week. Cells were used for 
experiments in passage 2 or 3. 
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MTT assay 
Cell viability was determined by the MTT assay according to (Mosmann, 1983) with some 
modifications. Briefly, cells were seeded in 96-well plate at a density of 104 cells per well 
and let to adhere overnight. Next, the cells were subjected to different oxygen conditions and 
subsequently treated as described throughout the text and Figure legends.  Untreated cells 
served as controls. After treatment, the cells were washed twice with PBS solution and 
incubated in DMEM (180 μl) containing 500 μg/ml 3- [4,5-dimetho-thiazol-2-yo]-2,5-
diphenyl tetrazolium bromide (MTT) (Fluka, St. Louis MO, USA) for 4 h at 37 °C. The 
medium containing MTT was then removed and replaced with 150 μl dimethyl sulphoxide 
(DMSO). The plate was agitated for 2 min allowing MTT-formazan to dissolve into DMSO 
completely. The absorbance was determined at 570 nm using a Tecan C200 Micro plate 
Reader. Cell viability was calculated according to the equation: Cell viability (%) = (the 
absorbance of experiment group/the absorbance of control group) ×100%. Cell viability at 
each tested condition was obtained from 8 parallel wells. The experiment was repeated three 
times. 
 
Measuring catalase activity 
The catalase activity of cell lysates was determined according to (Li and Schellhorn, 2007) 
with modifications. Decrease in H2O2 level was monitored at 240 nm in a reaction mixture 
containing 50 mM phosphate buffer (pH 7.0) and 10 mM H2O2 with 20 μg of total cell lysate 
(WCE). Catalase from bovine liver (Cat. #C30-100MG, Sigma-Aldrich, USA) was used as a 
standard. The specific inhibitor of catalase 3-AT was used to ensure the specificity of the 
assay (Darr and Fridovich, 1986). 5 mM 3-AT inhibited the catalase activity over 90 %. 
 
Measuring glutathione peroxidase (GSH-Px) activity 
The GSH-Px activity was measured according to (Flohe and Gunzler, 1984) in a reaction 
mixture containing 50 mM phosphate buffer (pH 7.0), 1 mM EDTA, 1 mM NaN3, 1 mM 
GSH, 10 mM H2O2, 2.5 U/ml GSH reductase, 150 pM NADPH, and 20 μg of whole cell 
protein extract. Consumption of NADPH was monitored at 340 nm. The GSH-Px activity 
was inhibited by 1.8 mM N-ethyl-maleimide (NEM) (Gregory et al., 1971). To ensure that 
NEM did not affect GSH reductase, oxidized GSH was added to the reaction mixture after 
activity determination. 
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IV. UNPUBLISHED RESULTS 
 
IV.1. THE BER CAPACITY AND CELL SURVIVAL UPON HYPOXIA ARE 
REGULATED VIA AKT DEPENDENT PHOSPHORYLATION OF hOGG1 
 
IV.1.1. BACKGROUND 
 
The expression of BER genes has been shown to be regulated in a complex manner often 
involving the integration of multiple pathways and levels of regulation (Zharkov, 2008). Previously, 
it has been demonstrated that hypoxia, or precisely hypoxic preconditioning, activated expression of 
hOGG1 and Pol  in a HIF dependent manner (Razumenko M., 2012) (see Manuscript on page 24.). 
Remarkably, both mRNA and protein levels of hOGG1 and Pol  were elevated during 16 hours of 
hypoxia treatment and, in case of Pol , reverted gradually to its basal values, during 120 min of re-
oxygenation. At the same time, hOGG1 protein levels were not significantly changed by re-
oxygenation (III.1. Fig. 1, A-C). Further investigation of hOGG1 protein levels by immunoblotting, 
during hypoxia and re-oxygenation in different cell lines, identified a post-translation modification 
of hOGG1, which by band size and electrophoretic mobility shift in an SDS-PAGE could be 
classified, accordingly to literature, as phosphorylation (Kovacs et al., 2003). Moreover, 
phosphorylation of hOGG1 protein was the only modification induced by hypoxia and was detected 
throughout 120 minutes of re-oxygenation, but, on the other hand, not at the start of hypoxic 
preconditioning. Knock-down of the hOGG1 gene using specific siRNA resulted in reduced mRNA 
and protein levels of hOGG1 gene, with proportional reduction of phosphorylation. It was, however, 
not completely eliminated, suggesting that HIF dependent elevation of hOGG1 expression, and its 
modification, are simultaneous, and possibly, independent events, since HEK293 cells that were 
stably transfected with shRNA for HIF-1α and were unable to induce hOGG1expression under 
hypoxia, were still able to phosphorylate the hOGG1 protein.  
In the literature, multiple modification of hOGG1 protein has been reported, although, not in 
the context of hypoxia, or hypoxic preconditioning (Hill et al., 2008) (Bhakat et al., 2006). In spite 
that phosphorylation of hOGG1 has been described as the most frequent modification, only few 
reports analyzed its influence on the regulation and function of hOGG1 (Hill et al., 2008). However, 
neither exact motives, nor pathways responsible for hOGG1 phosphorylation have been identified in 
the literature so far. Consequently, the biological role of the specific hOGG1 phosphorylation has 
been explored so far only to a limited extent. 
 
IV.1.2. MATERIALS AND METHODS (IN ADDTION TO III.1) 
 
           IV.1.2.1. CHEMICALS AND ANTIBODIES 
 
Isoform selective inhibitor of Akt VIII (Cat. #124018, Merck, Darmstadt, Germany) and 
inhibitor of PI3K GDC-0941 (Cat. #S1065, LuBioScience, Lucerne, Switzerland) were of analytical 
grade. Oligonucleotides for site-directed mutagenesis of hOGG1 (Table 2) and for RT-qPCR 
(Table 3) were synthesized by Mycrosynth (Balgach, Switzerland) and antibodies (Table 4) were 
purchased from different suppliers.  
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Table 2: List of oligonucleotides used for site-directed mutagenesis of hOGG1 
 
Code Mutant Oligonucleotides (5’->3’) (Start-End)  
 
Human OGG1, NM_002542.5  
 
S44A Ser44 -> Ala44 FW: CCTTCTGGACAAGCTTTCCGGTGGAG 
RV: CTCCACCGGAAAGCTTGTCCAGAAGG 
 
S51A Ser51 -> Ala51 FW: GTGGAGGGAGCAAGCTCCTGCACACTG 
RV: CAGTGTGCAGGAGCTTGCTCCCTCCAC 
 
S115A Ser115 -> Ala115 FW: GTATCACCACTGGGGTGCCGTGGACTCCCACTTC 
RV: GAAGTGGGAGTCCACGGCACCCCAGTGGTGATAC 
 
S211A Ser211 -> Ala211 FW: GTTACGTGAGTGCCGCTGCCCGAGCCATC 
RV: GATGGCTCGGGCAGCGGCACTCACGTAAC 
 
S340A Ser340 -> Ala340 FW: CGCAGAAAGGGTGCCAAAGGGCCGG 
RV: CCGGCCCTTTGGCACCCTTTCTGCG 
 
 
 
 
Table 3: List of oligonucleotide primers used in RT-qPCR 
 
Symbol Accession# Primers (5’->3’) (Start-End) PL, bps 
 
PKB (Akt) genes  
 
Akt1 NM_001014431.1 FW: catcacaccacctgaccaag 
RV: ctcaaatgcacccgagaaat (1684-1884) 
201 
Akt2 NM_001243027.1 FW: gaggtcatggagcacaggtt  
RV: ctggccgagtaggagaactg (1466-1695) 
230 
Akt3 NM_001206729.1 FW: cagtagactggtggggccta  
RV: atcaagagccctgaaagcaa  (1130-1298) 
169 
 
 
 
Table 4: List of primary antibodies 
 
Symbol Entrez-Gene ID/Protein Mw, kDa Cat. # Manufacturer 
 
PKB (Akt)    
 
Akt1 207, v-akt murine thymoma viral oncogene homolog 1 60 2938 Cell Signaling 
Akt2 208, v-akt murine thymoma viral oncogene homolog 2 60 5239 Cell Signaling 
Akt3 10000, v-akt murine thymoma viral oncogene homolog 3 60 4059 Cell Signaling 
PAktSer473	 Activated form of Akt (isoform unspecific antibody) 60 9271 Cell Signaling 
 
Others     
 
Phosphoserine phosphorylated serine amino acid  P5747 Sigma 
HA-tag human influenza hemagglutinin (HA)  05-904 Millipore 
 
 
 
           IV.1.2.2. SITE DIRECTED MUTAGENESIS, CELL FRACTIONATION, AND 
IMMUNOPRECIPTATION 
 
Site-directed mutagenesis and preparation of whole protein extracts for cell fractionation 
experiments were performed as described by Markkanen et al. (Markkanen et al., 2012). 
Immunoprecipitation of hOGG1 was performed using monoclonal anti-HA agarose conjugate 
(Clone HA-7) (Cat. #2095, Sigma, Bülach, Switzerland) accordingly to manufacturer’s instructions.  
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 IV.1.3. RESULTS 
 
IV.1.3.1. PHOSPHORYLATION OF hOGG1 UPON HYPOXIA IS AKT 
DEPENDENT  
 
 So far phosphorylation of hOGG1 has been identified on Ser340, protein kinase C (PKC) can 
carry out this (Dantzer et al., 2002). Thus, the primary question in this project was to identify 
putative phosphorylation sites of, along with potential kinase(s).  
By using NetPhosK 1.0 (http://www.cbs.dtu.dk/services/NetPhosK/) in silico prediction with 
mid-stringency thresholds (ν ≥ 0.55) five putative phosphorylation motives for 3 respective kinases 
were identified in the amino-acid sequence of hOGG1 (Fig. 15, A). The modified amino acid in all 
motives was serine, located in positions 44, 51, 115, 211 and 340, respectively. S44, S115 and S211 
were putative sites for protein kinase C (PKC), S51 for PKB and S340 for PKA, respectively. All 
kinases represent, however one family – ABC kinases (Newton, 2003). Remarkably, the only serine 
in position 51 formed so called SP-site known for its ability to distort secondary and tertiary protein 
structures upon phosphorylation, and thus to be detected as a corresponding band shift in SDS-
PAGE (Kovacs et al., 2003).  The role of each potential phosphorylation site was further 
investigated ex vivo. For this reason, all five serine residues were mutated to alanine by site-directed 
mutagenesis (Fig. 15, B). The resulted plasmid constructs were transfected into HEK293 cells 48 
hours prior to hypoxic preconditioning. Only the S51A mutant was detected with reduced 
phosphorylation after 16 hours of hypoxia, as compared with its wild type (WT) (Fig. 15, C), 
indicating an involvement of PKB (Akt) in phosphorylation of hOGG1. In the next step, specific 
siRNA were used to knock-down the expression of the PKB (Akt) kinase. Since the PKB family 
includes three members, being Akt1, Akt2, and Akt3, representing, 85%, 10% and 5 %, 
respectively, of PKB pool in the cell (Bellacosa et al., 2004), three different siRNA were used 
(Qiagen IDs: s102757244, s100287742, s101140326) (Fig. 15, D-E). Phosphorylation of WT 
hOGG1 under hypoxia was not affected by down- regulation of Akt1. On the other hand, down 
regulation of Akt2 resulted in reduced hOGG1 phosphorylation. The Akt3 mRNA could not be 
detected in HEK293 cells (Fig. 15, E-F). In order to determine, whether activation of Akt, is 
required to phosphorylate hOGG1, the selective Akt kinase family inhibitor VIII, referred as 
inhibitor 8 (INH8), was used to block activation of PKB ex vivo in a dose dependent manner. 
Treatment of HEK293 hOGG1WT cells with 2 µM of inhibitor 8 during the last 2 of 16 hours of 
hypoxia, prevented activation of all three Akt 1, 2 and 3 isoforms. This resulted in a 10 fold reduced 
hOGG1 phosphorylation. On the other hand, no change in hOGG1 phosphorylation was detected 
when INH8 was used at 200 nM or lower. This dose has been reported in the literature to inhibit the 
activation of the predominant Akt1 isoform, but without affecting other two, Akt2 and Akt3 (Zou et 
al., 2009) (Fig. 15, F), suggesting that phosphorylation of hOGG1 might be induced by Akt2.  
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Fig 15: Phosphorylation of hOGG1 under hypoxia is PKB (Akt) dependent. (A) In silico prediction of putative 
phosphorylation sites in the hOGG1 protein. Formatted output of NetPhosK 1.0 algorithm shown in the lower part, and SP-site is 
marked by black square (refer to the text for details); (B) SDM generated hOGG1 constructs; (C) Phosphorylation of hOGG1 
mutant constructs under hypoxia (0.2% O2) analyzed by immunoblotting. Representative experiment is shown; (D) Silencing of 
PKB (Akt) genes under hypoxia (0.2% O2). HEK293 cells were transfected with respective siRNA 48 hours prior to the treatment; 
(E) Expression of PKB (Akt) mRNAs in HEK293 cells under hypoxia (0.2% O2) analyzed by RT-qPCR; (F) Phosphorylation of 
hOGG1 mutant constructs under hypoxia (0.2% O2) and treatment with INH8 analyzed by immunoblotting. Representative 
experiment is shown; 
 
IV.1.3.2. PHOSPHORYLATION OF hOGG1 MODULATES ITS ACTIVITY AND 
CELLULAR LOCALIZATION DURING HYPOXIA  
 
Since it has been reported that phosphorylation of hOGG1 might alter its activity and 
localization in the cell (Dantzer et al., 2002), the functional role of hypoxia induced hOGG1 
phosphorylation was next tested. For this the cellular localization of hOGG1 during hypoxic 
preconditioning was analyzed by immunofluorescence. Over 73.2+/-4.9% (p<0.05) of the hOGG1 
protein was translocated from the cytoplasm to the nucleus upon 16 hours of hypoxia, and a 
significant portion of that (51+/-6.4%, p< 0.05) remained within the nuclear compartment following 
120 min of re-oxygenation (Fig. 16, A-B). Independently, analysis of cell fractionations after 
transfection of HEK293 cells with WT or mutated hOGG1 constructs indicated that the S51A 
mutant, that cannot be phosphorylated, was not present in nuclear fraction, and remained entirely 
within cytoplasm fraction, either during 16 hours of hypoxia, or 120 min of re-oxygenation, 
suggesting phosphorylation might be important for hOGG1 translocation (Fig. 16, C). The nuclear 
translocation of WT, but not S51A mutant, was reduced by 90% when cells were treated with 2 µM 
of INH8 during hypoxia, suggesting that Akt affects by phosphorylation of hOGG1 its cellular 
localization.   When HEK293 whole cell extracts (WCE), that were transfected with WT and mutant 
hOGG1 plasmid constructs, were compared in an in vitro BER assay, WCE of WT hOGG1 protein 
after hypoxic precondition had an 8 fold higher BER activity than either the S51A mutant under 
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hypoxia, or the WT hOGG1 protein without hypoxic preconditioning (Fig. 16, D). Again, treatment 
of HEK293 WT hOGG1 cells, during hypoxic preconditioning, with 2 µM of INH8, returned the 
activity of hOGG1 mediated BER to the levels observed for S51A mutant under hypoxia, or for the 
WT hOGG1 without hypoxic preconditioning (Fig. 16, E). Moreover, knock-down of Akt2, but not 
Akt1 with specific siRNA reduced the activity of hOGG1 WT mediated BER by 7 fold (Fig. 16, F-
G), suggesting that the BER capacity is indeed dependent on Akt2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16: Phosphorylation of hOGG1 modulates its activity and cellular localization during hypoxia. (A)	 Intracellular 
localization hOGG1 analyzed by immunofluorescence with a specific antibody. (B) Mean fluorescence intensity of nuclear 
hOGG1 fraction calculated for 200 cells +/- SEMs in A.  (C) Intracellular localization hOGG1 upon hypoxia analyzed by cell 
fractionation and immunoblot. Representative samples are shown. (D) In vitro BER assay of HEK293 WCEs transfected with WT 
and hOGG1 mutants and cultured for 16 hours at respective oxygen atmosphere. (E) Same as in F but cells were treated with 
INH8, or (F-G) PKB (Akt) was silenced by specific siRNA. Shown are mean values of incorporation of radioactively labeled [α-
P32] dGTP on S2 subtracted to control +/- SEMs of three experiments. 
 
 
 
 
65	
	
IV.1.3.3. PHOSPHORYLATION OF hOGG1 IN RESPONSE TO HYPOXIA IS 
NECESSARY TO PROMOTE CELL SURVIVAL AND RESISTANCE TO DNA 
DAMAGING AGENTS 
 
 In order to investigate role of hOGG1 phosphorylation in cell survival a colony forming 
assay was used. Initially, the survival of mouse embryonic fibroblasts (MEF) knocked-out for 
hOGG1 gene (MEF OGG1-/-) was compared to the survival of MEFs complemented by the WT 
hOGG1 plasmid, or by the hOGG1 phosphorylation mutants during hypoxia and re-oxygenation. 
Significantly lower (29.8+/-2.8%, p< 0.05; 24.1+/-1.3%, p<0.05) number of colonies were counted 
past 7 days after hypoxic precondition, for both, hOGG1-/- cells or the same cells transfected with 
S51A mutant, as compared to the MEFs complemented with WT hOGG1 (hOGG1+/+) construct 
(Fig. 17, A). Moreover, treatment of hOGG1-/- cells or hOGG1-/- cells transfected with the S51A 
construct, at either 1 mM H2O2	 (Fig. 17, B), 100 mM of methyl methanesulfonate (MMS) (Fig. 17, 
C) or 3 Gy of γ-irradiation (Fig. 17, D) during 120 minutes of re-oxygenation, resulted in further 
decrease of colony counts.  hOGG1+/+ cells were tolerating such a treatment at a large extent and 
only a negligible reduction in colony counts was observed (Fig. 17, B-D). This suggested that 
phosphorylation of hOGG1 is required for survival. Furthermore, treatment of hOGG1+/+ cells with 
2 µM of INH8 (Fig. 17, E-G), or with 100 nM of GDC-0941 (Fig. 17, H-J), a specific inhibitor of 
PI3K kinase acting upstream of PKB during hypoxia, reduced survival after treatment with 
damaging agents to levels comparable with survival of hOGG1-/- MEFs or the hOGG1-/- MEFs 
transfected with the S51A mutant, suggesting survival and stress tolerance are dependent on the 
active PKB signaling. Decreased survival in response to treatment with DNA damaging agents was 
also observed when hOGG1+/+ cells were transfected with siRNA for Akt2, but not with siRNA for 
Akt1 (Fig. 17, K-P)   
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Fig. 17: Phosphorylation of hOGG1 in response to hypoxia is necessary to promote cell survival and resistance to DNA 
damaging agents. Colony formation assay of MEF hOGG1+/+, hOGG1-/- and hOGG1S51A cells (A) subjected to hypoxia and re-
oxygenation, or treated with (B) 1 mM H2O2 (C) 100 nM MMS (D) 3 Gy of γ-irradiation, during 120 minutes of re-oxygenation; 
(E-G) threated the same as in B-D plus INH8 (H-J) threated the same as in B-D plus GDC-0941; (K-P) threated the same as in B-
D plus PKB (Akt) siRNA mediated silencing. The mean values +/- SEMs of three experiments are shown.  
 
 
IV.1.3.4. EXPRESSION OF hOGG1 AND AKT ISOFORMS IS ELEVATED IN 
HUMAN TUMORS  
 
 As the next step, expression of hOGG1 and PKB in human tumors was analyzed. Splenic 
marginal zone lymphoma (SMZL) was selected for this reason, as a variant of human tumor, that is, 
by histology and pathogenesis, closely related to non-Hodgkin, non-metastatic lymphomas, derived 
from spleen of dogs and previously analyzed in this thesis (Section III.1., Fig. 4, A-C). Grade N2 of 
SMZL was considered as comparable, by morphological changes, to the grade IIB, of mentioned 
dog’s NHL. Tumor biopsies, in the case of SMZL, were also matched to non-transformed splenic 
tissue, derived during surgery. Five matched pairs were used to analyze mRNA levels of hOGG1, 
Pol β and PKB (Akt), isoforms 1 (Akt1) and 2 (Akt2) (Fig. 18, A). Levels of mRNA for all four 
studied genes were elevated 6.12, 3.26, 2.73 and 4.94 fold, respectively, in SMZL samples as 
compared to non-transformed tissue (Fig. 18, A). The values were normalized in all cases to 
ribosomal protein L28 (RPL28) and also to the content of CD20+ B-cells in non-transformed (Fig. 
18, B, left) and tumor (Fig. 18, B, right) tissues. Simultaneously, increased expressions of both 
hOGG1 and the two PKB isoforms might be in this case an indirect indication for their dependent 
involvement in tumor genesis. This conclusion, however, urges for further investigation.   
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Fig. 18: Expression of hOGG1 and Akt isoforms is elevated in human tumors (A) mRNA expression levels of hOGG1, 
POLB and two PKB (Akt) genes in SMZL samples (n=5) analyzed by RT-qPCR. Shown are mean values +/- SEMs. (B) 
Fractionation of splenic post-mortem samples (left) and SMZL tumor samples (right) by flow cytometry. Percentage of positive 
cells is indicated, +/- SEM. 
 
 
 IV.1.4. CONCLUDING REMARKS AND PROSPECTIVES 
 
 Phosphorylation of hOGG1 has been described as the most frequent post-translational 
modification  (Hill et al., 2008) introduced in response to multiple stimuli, including genotoxic 
stress (Bhakat et al., 2006). Frequent phosphorylation of the protein can partially be explained by its 
amino-acid composition. Thus, hOGG1 contains polar amino-acids in its primary structure in 
relatively high density, 11%. Among them are seventeen serine, five tyrosine and three threonine 
residues that can be phosphorylated (Ishida et al., 1999). This makes mapping and detailed 
characterization of the phosphorylation sites to be very complex, which is illustrated by the fact that 
only phosphorylation of Ser340 has been characterized and reported up to date (Dantzer et al., 
2002).  
In silico approaches are used to study phosphorylation, although subsequent verification of 
such results is required. Using NetPhosK algorithms, it was possible to identify five potential 
phosphorylation sites, one of which, Ser51, was phosphorylated by PKB (Akt) kinase in response to 
hypoxia, which also was confirmed by the analysis of non-phosphorylated hOGG1 mutants. Despite 
many advantages the NetPhosK service is limited to the use of pre-defined parameters set by the 
system, such as stringency value (ν) and sensitivity (ρ), misuse of which can generate false positive 
and/or false negative hits. In this context, whole proteome identification of phosphorylation sites by 
mass-spectrometry (MS) (Munton et al., 2007)  is an alternative approach that allows identification 
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of phosphorylation sites in vivo. MS was also applied in this thesis project.  These data have, 
however, not yet been available for this discussion.  
In order to verify role of PKB in the phosphorylation of hOGG1, a loss-of-function 
experiment was performed. Using siRNA silencing of Akt kinase isoforms, Akt2 was identified to 
catalyze Ser51 phosphorylation in response to hypoxia. It was confirmed also by use of selective 
isoform specific inhibitor of PKB (Akt) and hOGG1 mutant constructs. However, in vitro 
phosphorylation of purified hOGG1 protein by activated PKB, isoform 1 (Akt1), have not resulted 
in any detectible hOGG1 phosphorylation, in contrast to the known substrate of PKB, p21 that was 
used as a positive control. Remarkably, the catalytic domain of PKB is highly conserved between 
all three isoforms, and main differences between isoforms consist of the regulatory C-terminal part 
of the protein (Bellacosa et al., 2004). In this context, failure to phosphorylate hOGG1 in vitro, on 
the one hand, might indicate inability to fully reconstitute parameters of the kinase reaction held in 
vivo, but on the other hand, it might also indicate an important role of protein-protein interactions in 
phosphorylation of hOGG1 under hypoxia. In prospective, generation of enzymatically inactive 
and/or truncated PKB (Akt) mutant constructs will be required to elucidate details of the mechanism 
of hOGG1 phosphorylation, which still remains only merely investigated. 
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V. SUMMARY OF THE MAJOR FINDINGS 
 
V.1. Hypoxia activates expression of core BER genes. 
 
- Pol λ (POLL), Pol β (POLB) and hOGG1 are up-regulated by hypoxia, and their increased 
expression is maintained during the whole period of re-oxygenation, in spite of gradual decline  
- MUTYH and Ape-1 are O2 irresponsive and, in absence of other factors, are constantly 
expressed independently of O2 availability   
 
V.2. HIF and PKB pathways, but not the amount of ROS or base damages in the cell, 
regulate core BER genes in response to hypoxia and re-oxygenation. 
 
- Expression of Pol β and hOGG1 is regulated via HIF-1α, and expression of pol λ is 
controlled by the mTOR kinase. 
- PKB isoform 2 (Akt2) phosphorylates hOGG1 protein in response to hypoxia promoting its 
nuclear translocation and increasing its enzymatic activity. 
 
V.3. Up-regulated expression of core BER genes results in elevated capacity of hOGG1 
and MUTYH initiated DNA repair, thus leading to excessive stress tolerance and increased 
cell survival upon genotoxic stress. 
 
V.4. Activation of core BER genes in human and animal solid tumors, correlates with 
degree of tumor hypoxia, aggressiveness of the neoplasms, and contributes to the therapeutic 
resistance of the tumors. 
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VI. FINAL DISCUSSION 
 
Oxygen, which constitutes 20% of the earth’s atmosphere, is also the most abundant element 
in the human body (65%) (Maltepe and Saugstad, 2009).  
Such prevalence of oxygen in the human body is partially due to high content of oxygen 
atoms in bioorganic molecules, used as building blocks for cellular and tissue structures. However, 
substantial part of oxygen in human body is molecular gas (O2) dissolved in human fluids and 
indispensable for aerobic organisms to produce energy by oxidative phosphorylation in the 
mitochondria. In this process the reduction of O2 to water by the mitochondrial electron transport 
chain enables the conversion of adenosine diphosphate (ADP) into adenosine triphosphate, ATP. 
The consequence of this reaction is the formation of reactive oxygen species, which in spite of their 
physiological value, can also lead to toxic effects and diseases if accumulated in excessive amounts 
(Bertram and Hass, 2008). 
   ROS are constantly produced in the cellular metabolism and the majority of them are readily 
detoxified via cellular antioxidant defense systems, except cases, known as oxidative stress, when 
production of ROS exceeds cell's ability to eliminate reactive intermediates or to repair the resulting 
damage (Valko et al., 2007). 
 Oxidative stress is often associated with normal physiological functions of cells and 
organism, like active tissue proliferation, organ regeneration or intensive physical activity (Fruehauf 
and Meyskens, 2007), but still majority of conditions are pathological, including the most severe – 
tumor development (Schumacker, 2006).  
The main issue of oxidative stress is damage to DNA that affects genomic stability, and thus 
plays a key role in tumor initiation and maintenance, which is demonstrated by high content of 
mutations, arising from oxidative lesions, in human tumors (Campbell et al., 2010). In unperturbed 
cells, base excision repair (Zharkov, 2008) is the essential pathway to effectively combat oxidative 
DNA damages and in particular, the most mutagenic of it, 8-oxo-guanine, detected in high amounts 
during oxidative stress (Klaunig and Kamendulis, 2004). Therefore, oxidative stress is a critical 
cellular condition that requires BER activity to be adjusted in accordance to it extent. 
Almost 80% of intracellular ROS are generated through oxidative phosphorylation, which is 
driven by partial O2 reduction in mitochondria, thus fluctuations in O2 availability and consumption 
are the primary cause of oxidative stress under physiological conditions and also the main reason 
why all eukaryotic organisms maintain an oxygen homeostasis (Semenza, 2010). If adaptation to 
low O2, mediated by HIF has been extensively studied (Semenza, 2007), mechanisms to protect and 
repair the DNA of a cell working at higher or very often fluctuating O2 concentrations, are still 
poorly understood (van Loon et al., 2010). 
The aim for this thesis was to elucidate potential mechanisms that control expression of core 
BER genes in response to differential O2 availability. In contrast to previously reported inactivation 
of DNA repair systems, including homologous recombination and non-homologous and joining 
(NHEJ) (Chan et al., 2008), at low O2 concentration, expression of core BER genes and resulted 
BER capacity were increased under hypoxia and remain unaffected long after re-oxygenation. This 
might indicate differential involvement of DNA repair machines, which starts from inactivation of 
energy consuming pathways and switching on the pathways, like BER, needed to combat additional 
oxidative damage caused by restored O2 supply. This hypothesis was further supported by 
involvement of HIF-1α and mTOR, key regulators of gene expression under hypoxia, in activation 
of core BER genes. More importantly in this aspect, that activation of BER genes and increase in 
BER capacity were uncoupled from the amount of ROS produced or the content of oxidative DNA 
lesions, thus allowing BER to be directly controlled via O2 sensing and signaling roots and not via 
DNA damage, as in this case it would prevent BER from activation under hypoxia, and 
consequently lead to intolerance to oxidative damage raised either from re-oxygenation or oxidative 
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stress. Besides, the involvements HIF and mTOR, the BER capacity was also affected by 
posttranslational modifications. In particular, phosphorylation of hOGG1 via Akt2 increased 
activity and nuclear translocation of the protein, resulting in even higher BER capacity after re-
oxygenation. This, on the one hand, might be just a second level in regulation BER function, but on 
the other hand, dual control mechanism that integrates also sensing of nutrients along to O2 
availability, could be general way of cell adaptation to chronic periods of hypoxia and re-
oxygenation, which are common to many developmental processes.   
Furthermore, activation of core BER genes by hypoxia that resulted in increase of the BER 
capacity was necessary to tolerate excessive DNA damage caused either by re-oxygenation or by re-
oxygenation and genotoxic stress together. Using the siRNA approach hOGG1 and DNA pol β were 
identified as main factors of elevated DNA damage resistance. Remarkably the same mechanism of 
BER activation and the same BER genes were responsible for extreme resistance to DNA damaging 
agents, including therapeutic drugs, by re-oxygenated revived tumor cells ex vivo. Independently of 
the type or stage of tumor, and organism source, all solid tumors included in this thesis and their 
isolated cells were therapeutic resistant which correlated with their hypoxic status, expression of 
BER genes and of some pro-survival markers, like Akt2, highlighting the critical role of BER and 
hypoxia interplay in developing anti-cancer drug resistance. It was independently although 
indirectly supported by a recent report (Zhang et al., 2010). 
The forces of BER activation in vivo are still awaiting further elucidation. In this direction, 
multiple reports highlight the importance of tissue O2 dynamics. Impressively, the dynamics of 
perfusion and O2 persistence in the tissue ranges from just 20 milliseconds, in mouse brain under 
stress (Shen et al., 2009), to many days in a developing human embryo (Dunwoodie, 2009). Tumor 
tissue known for its chaotic vascularization is an excellent example. A high rate of cell proliferation 
in addition to dysfunctional perfusion constantly induces intermittent hypoxia in the growing tumor 
mass (Matsumoto et al., 2010), thereby activating BER genes. Finally, the littoral crab (Carcinus 
maenas), which can dive up to 40 meters deep and returns back to sea level, is repeatedly exposed 
to O2 concentrations between 0.01% and 20% for at least 30 times a day known for its high stress 
tolerance (Taylor, 1976). Conclusively, the mentioned processes would all be deleterious for living 
cells and organisms due to increased ROS production and high rate of oxidative DNA damage 
unless a general mechanism to combat that danger would exist as an “insurance” and can be 
adjusted accordingly to potential needs to sudden changes in the environment or in the body. Such 
changes in the body can be physiological as well as pathological (e.g. cancer microenvironment). 
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